WO2023277194A1 - Sunscreen w/o emulsion - Google Patents

Sunscreen w/o emulsion Download PDF

Info

Publication number
WO2023277194A1
WO2023277194A1 PCT/JP2022/026534 JP2022026534W WO2023277194A1 WO 2023277194 A1 WO2023277194 A1 WO 2023277194A1 JP 2022026534 W JP2022026534 W JP 2022026534W WO 2023277194 A1 WO2023277194 A1 WO 2023277194A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
less
composition according
composition
filter
Prior art date
Application number
PCT/JP2022/026534
Other languages
French (fr)
Inventor
Tomomi HAMAZAKI
Toru Koike
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2021108691A external-priority patent/JP2023006211A/en
Priority claimed from FR2108145A external-priority patent/FR3125707A1/en
Application filed by L'oreal filed Critical L'oreal
Priority to KR1020237045187A priority Critical patent/KR20240013245A/en
Priority to CN202280047046.1A priority patent/CN117597102A/en
Publication of WO2023277194A1 publication Critical patent/WO2023277194A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/064Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426Polymers characterized by specific structures/properties characterized by the charge cationic

Definitions

  • the present invention relates to a W/O emulsion composition, in particular a sun care composition in the form of a W/O emulsion, for a keratinous substance such as skin.
  • Sun care products are widely used in order to protect keratinous substances, in particular skin, from the damage caused by UV radiation.
  • W/O emulsion sun care compositions are widely distributed since they are in general water resistant and thus can be retained on the surface of the skin even after exposed to water or sweat.
  • JP-A-2009-191033 discloses a water-in-oil type sunblock cosmetic including: (A) a partially crosslinked polyester modified organopolysiloxane; (B) an organic titanate-treated fine particulate zinc oxide and/or an organic titanate-treated fine particulate titanium oxide; (C) a silicone oil; (D) one or more oily agents selected from glyceryl trioctanoate, glyceryl tri(capryl- capric acid), and dioctanoic acid neopentyl.
  • JP-A-2020-97552 discloses a cosmetic preparation for concavo-convex compensation containing the following components (a) to (d): (a) 6 to 10 wt.% of fumed hydrophobic silica; (b) 5 to 20 wt.% of octamethyltrisiloxane and/or decamethyltetrasiloxane; (c) batyl alcohol; and (d) 10 to 30 wt.% of powders other than (a) that contain no microplastic beads, the cosmetic preparation for concavo-convex compensation containing no microplastic beads.
  • organic UV filters are widely used to impart a UV protecting property to sun care compositions.
  • W/O emulsion compositions comprising organic UV filters, which are well resistant to water resistant, impart an improved texture, such as a fresh sensation, and have good stability without causing phase separation over time. Furthermore, sun care cosmetic compositions which do not contain microplastic fillers are also desired as environmentally-sustainable products.
  • An objective of the present invention is to provide a water-resistant W/O emulsion composition having an improved texture, such as a fresh sensation and having good stability, and not comprising microplastic fillers.
  • W/O emulsion composition comprising:
  • composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.
  • the (b) powder may be selected from talc, mica, silica, silica silicate, magnesium aluminum silicate, kaolin, bentone, calcium carbonate, magnesium hydrogen carbonate, hydroxyapatite, boron nitride, fluorphlogopite, sericite, calcinated talc, calcinated mica, calcinated sericite, synthetic mica, perlite, lauroyl lysine, metal soap, bismuth oxychloride, barium sulfate, magnesium carbonate, and natural polymer powders, such as polysaccharide powders, for example, starch, cellulose powder, and mixtures thereof.
  • natural polymer powders such as polysaccharide powders, for example, starch, cellulose powder, and mixtures thereof.
  • the average particle size of the (b) powder may be 50 pm or less, preferably 20 pm or less, and more preferably 15 pm or less, and may be 0.2 pm or more, preferably 0.5 pm or more, and more preferably 1 pm or more.
  • the (c) cationic polymer may be selected from quatemized hydroxyethyl celluloses modified with at least one quaternary ammonium group comprising at least one fatty chain
  • the (c) cationic polymer may be selected from quatemized alkylhydroxyethylcelluloses containing C 8 -C 30 fatty chains.
  • composition according to the present invention may be free of microplastic filler.
  • the (a) lipophilic organic UV filter may comprise a combination of at least one lipophilic organic UV-A filter and at least one lipophilic organic UV-B filter.
  • the amount of the (a) lipophilic organic UV filter(s) may be 1% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, and/or may be 50% by weight or less, preferably 40% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less, relative to the total weight of the composition.
  • the amount of the (b) powder(s) may be 1% by weight or more, preferably 3% by weight or more, more preferably 5% by weight or more, even more preferably 8% by weight or more, and in particular 10% by weight or more, and/or may be 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, even more preferably 18% by weight or less, and in particular 15% by weight or less, relative to the total weight of the composition.
  • the amount of the (c) cationic polymer(s) may be 0.001% by weight or more, preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, and/or may be 5% by weight or less, preferably 3% by weight or less, more preferably 1% by weight or less, and even more preferably 0.5% by weight or less, relative to the total weight of the composition.
  • the amount of the (d) oil(s) may be 3% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, and in particular 20% by weight or more, and/or may be 50% by weight or less, preferably 40% by weight or less, more preferably 35% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
  • composition according to the present invention may further comprise at least one inorganic UV filter.
  • the inorganic UV filter may have an average particle size of less than 200 nm.
  • the amount of the inorganic UV filter may be 0.5% by weight or more, preferably 1% by weight or more, and more preferably 1.5% by weight or more, and may be 15% by weight or less, preferably 10% by weight or less, more preferably 7% by weight or less, and even more preferably 5% weight or less, relative to the total weight of the composition.
  • the present invention also relates to a cosmetic process for a keratin substrate, such as skin, comprising applying to the keratin substrate the composition according to the present invention.
  • a W/O emulsion composition comprising a combination of at least one lipophilic organic UV filter, at least one powder other than microplastic filler, and at least one cationic polymer in the water phase can show an improved water resistant property, fresh sensation on application, and good stability, even if it is free of microplastic filler, and thus completed the present invention.
  • the present invention relates to a W/O emulsion composition, comprising:
  • composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.
  • composition according to the present invention includes (a) at least one lipophilic organic UV filter, and (b) at least one powder other than microplastic filler, (c) at least one cationic polymer, and (d) at least one oil.
  • the ingredients in the composition will be described in a detailed manner below.
  • the composition according to the present invention comprises (a) at least one lipophilic organic UV filter. Two or more lipophilic organic UV filters may be used in combination. Thus, a single type of lipophilic organic UV filter or a combination of different types of lipophilic organic UV filters may be used.
  • UV here comprises the UV-B region (260-320 nm in wavelength), the UV-A region (320-400 nm in wavelength), and the high energy visible light region (400-450 nm in wavelength). Therefore, a UV filter means any material which has filtering effects in the wavelength of UV rays, in particular the UV-A, UV-B, and high energy visible light regions.
  • the UV filter(s) used for the present invention may be active in the UV-A and/or UV-B region, preferably in each of the UV-A and UV-B regions alone or in combination. Therefore, the UV filter(s) used in the present invention include(s) a UV-A filter capable of absorbing UV radiation from 320 to 400 nm, a UV-B filter capable of absorbing UV radiation from 280 to 320 nm, and a UV-A and UV-B filter capable of absorbing UV radiation from 280 to 400 nm.
  • lipophilic UV filter here means UV filters which are soluble in oils at a concentration of at least 1% by weight relative to the total weight of the oils at room temperature (25°C) and atmosphere pressure (10 5 Pa).
  • the lipophilic organic UV filter may be solid or liquid.
  • solid and liquid mean solid and liquid, at room temperature (25 °C) and atmosphere pressure (105 Pa).
  • the lipophilic organic UV-A filters used in the present invention may include, but are not limited to, aminobenzophenone compounds, dibenzoylmethane compounds, anthranilic acid compounds, and 4,4-diarylbutadiene compounds.
  • n-hexyl 2-(4-diethlamino-2- hydroxybenzoyl)benzoate the alternative name of which is diethylamino hydroxybenzoyl hexyl benzoate (DHHB), sold under the trade name “Uvinul A+” from BASF.
  • DHHB diethylamino hydroxybenzoyl hexyl benzoate
  • dibenzoylmethane compounds mention may be made of 4-isopropyldibenzoylmethane, sold under the name of “Eusolex 8020” from Merck, l-(4-methoxy-l-benzofuran-5-yl)-3- phenylpropane-l,3-dione, sold under the name of “Pongamol” from Quest, l-(4-(tert- butyl)phenyl)-3-(2-hydroxyphenyl)propane-l,3-dione, and butyl methoxydibenzoylmethane, sold under the trade name “Parsol 1789” from Hoffmann -La Roche.
  • 4,4-diarylbutadiene compounds mention may be made of 1,1 -dicarboxy (2,2'- dimethylpropyl)-4,4-diphenylbutadiene and diphenyl butadiene malonates and malononitriles.
  • the lipophilic organic UV-B filters used in the present invention may include, but are not limited to, triazine compounds, para-aminobenzoic acid compounds, salicylic compounds, cinnamate compounds, b,b-diphenylacrylate compounds, benzylidenecamphor compounds, phenylbenzimidazole compounds, imidazoline compounds, benzalmalonate compounds, and merocyanine compounds.
  • triazine compounds mention may be made of ethylhexyl triazone, marketed under the name “UVINUL T-150” by BASF, diethylhexyl butamido triazone, marketed under the name “UVASORB HEB” by SIGMA 2V, 2,4,6-tris(dineopentyl 4 , -aminobenzalmalonate)-s-triazine, 2,4,6-tris(diisobutyl 4’-aminobenzalmalonate)-s-triazine, 2,4-bis(dineopentyl 4’- aminobenzalmalonate)-6-(n-butyl 4 , -aminobenzoate)-s-triazine, and 2,4-bis(n-butyl 4’- aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine.
  • UVINUL T-150 by BASF
  • para-aminobenzoic acid derivatives mention may be made of para-aminobenzoates (PABA), for example, ethyl PABA (para-aminobenzoate), ethyl dihydroxypropyl PABA, and ethylhexyl dimethyl PABA, marketed under the name “ESCALOL 5972 from ISP.
  • PABA para-aminobenzoates
  • salicylic compounds mention may be made of homosalate, marketed under the name “Eusolex HMS” by Rona/EM industries, and ethylhexyl salicylate, marketed under the name “NEO HELIOPAN OS” by Symrise.
  • ethylhexyl methoxycinnamate marketed under the name “PARSOL CX” by DSM NUTRITIONAL PRODUCTS
  • isopropyl ethoxy cinnamate isoamyl methoxy cinnamate, marketed under the name “NEO HELIOPAN E 1000” by Symrise, diisopropyl methylcinnamate, cinoxate, and glyceryl ethylhexanoate dimethoxycinnamate.
  • octocrylene marketed under the name “UVINUL N539” by BASF
  • etocrylene marketed under the name “UVINUL N35” by BASF.
  • benzylidenecamphor compounds mention may be made of 3-benzylidene camphor, marketed under the name “MEXORYL SD” from CHIMEX, methylbenzylidene camphor, marketed under the name “EUSOLEX 6300” by MERCK, polyacrylamidomethyl benzylidene Camphor, marketed under the name “MEXORYL SW” by CHIMEX, and terephthalylidene dicamphor sulfonic acid, marketed under the name “Mexoryl SX” by Chimex.
  • phenylbenzimidazole compounds mention may be made of phenylbenzimidazole sulfonic acid, marketed under the name “Eusolex 232” by Merck, and disodium phenyl dibenzimidazole tetrasulfonate, marketed under the name “Neo Heliopan AP” by Haarmann and Reimer.
  • imidazoline compounds mention may be made of ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
  • benzalmalonate compounds mention may be made of polyorganosiloxane containing a benzalmalonate moiety, for example, Polysilicone- 15, marketed under the name “Parsol SLX” by DSM NUTRITIONAL PRODUCTS, and di-neopentyl 4'-methoxybenzalmalonate.
  • the lipophilic organic UV filters of the present invention may comprise lipophilic organic UV-A and UV-B filters, which cover UV-A and UV-B regions.
  • Benzophenone compounds such as benzophenone-1 marketed under the name “UVINUL 400” by BASF, benzophenone-2 marketed under the name “UVINUL 500” by BASF, benzophenone-3 or oxybenzone marketed under the name “UVINUL M40” by BASF, benzophenone-6 marketed under the name “Helisorb 11” by Norquay, benzophenone-8 marketed under the name “Spectra- Sorb UV-24” by American Cyanamid, benzophenone- 10, benzophenone-11, and benzophenone- 12; - benzotriazole compounds such as drometrizole trisiloxane marketed under the name “Silatrizole” by Rhodia Chimie, bumetrizole marketed under the name “TINOGUARTD AS” by CIBA- GEIGY ,and , phenylbenzotriazole derivatives: 2-(2H-benzotriazole-2-yl)-6-dodecyl-4-
  • benzoxazole compounds such as 2,4-bis[5-(l-dimethylpropyl) benzoxazol-2-yl(4- phenyl)imino]-6-(2-ethylhexyl)imino-l,3,5-triazine marketed under the name “Uvasorb K2A” by Sigma 3 V.
  • the lipophilic organic UV filter may be selected from aminobenzophenone compounds, such as diethylamino hydroxybenzoyl hexyl benzoate (DHHB), dibenzoylmethane compounds, such as butyl methoxydibenzoylmethane, triazine compounds, such as ethylhexyl triazone, salicylic compounds, such as homosalate, b,b-diphenylacrylate compounds, such as octocrylene, and benzotriazole compounds, such as drometrizole trisiloxane, and mixtures thereof.
  • aminobenzophenone compounds such as diethylamino hydroxybenzoyl hexyl benzoate (DHHB)
  • dibenzoylmethane compounds such as butyl methoxydibenzoylmethane
  • triazine compounds such as ethylhexyl triazone
  • salicylic compounds such as homosalate
  • the lipophilic organic UV filter of the present invention comprises a combination of at least one lipophilic organic UV-A filter and at least one lipophilic organic UV-B filter.
  • the lipophilic organic UV filter comprises at least one lipophilic organic UV-A filter selected from aminobenzophenone compounds and dibenzoylmethane compounds, and at least one lipophilic organic UV-B filter selected from triazine compounds, salicylic compounds, b,b-diphenylacrylate compounds, and benzotriazole compounds.
  • the amount of the lipophilic organic UV filter(s) in the composition according to the present invention may be 1% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, relative to the total weight of the composition.
  • the amount of the lipophilic organic UV filter(s) in the composition may be 40% by weight or less, preferably 35% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less, relative to the total weight of the composition.
  • the amount of the lipophilic organic UV-A filter(s) in the composition is 0.5% by weight or more, preferably 1% by weight or more, and more preferably 2% by weight or more, and is 15% by weight or less, preferably 10% by weight or less, and more preferably 7% by weight or less, relative to the total weight of the composition.
  • the amount of the lipophilic organic UV-B filter(s) in the composition is 1% by weight or more, preferably 5% by weight or more, and more preferably 8% by weight or more, and is 30% by weight or less, preferably 20% by weight or less, and more preferably 15% by weight or less, relative to the total weight of the composition.
  • the amount of the lipophilic organic UV-A and UV-B filter(s) in the composition is 0.5% by weight or more, preferably 1% by weight or more, and more preferably 1.5% by weight or more, and is 10% by weight or less, preferably 7% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.
  • the composition according to the present invention comprises (b) at least one powder other than microplastic filler. Two or more powders may be used in combination. Thus, a single type of powder or a combination of different types of powders may be used.
  • binder should be understood as meaning colorless or white, mineral or natural particles of any shape, which are insoluble in the medium of the composition, irrespective of the temperature at which the composition is manufactured.
  • the (b) powder is selected from powders other than microplastic fillers.
  • microplastic filler here means a synthetic polymer filler having an average particle size of 5 mm or less.
  • microplastic filler here is also understood to mean polymeric solid particle insoluble in water which has size less than 5mm (all dimension) and stable throughout the life cycle.
  • the microplastic filler may include, but not limited to, acrylic polymer powders, silicone powders, wax powders, polyamide powders, urethane polymer powders, tetrafluoroethylene polymer powders, polyacrylonitrile powders, poly- ⁇ -alanine powders, polyethylene powders, polytetrafluoroethylene powders, lauroyllysine, tetrafluoroethylene polymer powders.
  • the (b) powder may be of any shape, platelet-shaped, spherical or oblong, irrespective of the crystallographic form (for example lamellar, cubic, hexagonal, orthorhombic, etc.).
  • the average particle size of the (b) powder is not limited, but in general is 50 pm or less, preferably 20 pm or less, and more preferably 15 pm or less.
  • the average particle size of the (b) powder is 0.2 pm or more, preferably 0.5 pm or more, and more preferably 1 pm or more.
  • the term “average particle size” used herein represents a number-average size mean diameter which is given by the statistical particle size distribution to half of the population, referred to as D50.
  • the number-average size mean diameter can be measured by a laser diffraction particle size distribution analyzer, such as Mastersizer 2000 by Malvern Corp.
  • the (b) powder can be an inorganic or organic powder, which may or may not be surface-coated.
  • inorganic powder mention may be made of talc, mica, silica, silica silicate, magnesium aluminum silicate, kaolin, bentone, calcium carbonate, magnesium hydrogen carbonate, hydroxyapatite, boron nitride, fluorphlogopite, sericite, calcinated talc, calcinated mica, calcinated sericite, synthetic mica, perlite, lauroyl lysine, metal soap, bismuth oxychloride, barium sulfate, magnesium carbonate, and mixtures thereof, optionally hydrophilic- or hydrophobic-treated.
  • organic powder mention may be made of natural polymer powders, such as polysaccharide powders and derivatives thereof, for example, starch, cellulose powder, and mixtures thereof.
  • the (b) powder of the present invention is different from a so-called “inorganic UY filter”, such as titanium oxide.
  • the (b) powder does not have an active, substantive UV filtering effect, while it can contribute to form a homogeneous and fine film on keratinous substances, such as skin, by the composition according to the present invention. Therefore, the (b) powder of the present invention is not an inorganic UV filter, such as titanium oxide.
  • inorganic UV filler is characterized by its fine particle size, and generally has less than 200 nm of average particle size.
  • the (b) powder may or may not be surface-coated.
  • the coating may be an inorganic substance and/or an organic substance. In one embodiment of the present invention, the (b) powder is not surface-coated.
  • the inorganic coating may be selected from metal oxides, such as silica, aluminum oxides, titanium oxides, zirconium oxides, cerium oxide, chromium oxide, and iron oxides, and metal hydroxides, such as aluminum hydroxide.
  • metal oxides such as silica, aluminum oxides, titanium oxides, zirconium oxides, cerium oxide, chromium oxide, and iron oxides
  • metal hydroxides such as aluminum hydroxide.
  • the organic coating may be selected from fatty acids or salts thereof (such as sodium, potassium, zinc, iron or aluminum salts), fatty alcohols, lecithin, amino acids, polysaccharides, proteins, alkanolamines, waxes such as beeswax, (meth)acrylic polymers, and (per)fluoro compounds.
  • fatty acids or salts thereof such as sodium, potassium, zinc, iron or aluminum salts
  • fatty alcohols such as sodium, potassium, zinc, iron or aluminum salts
  • lecithin amino acids
  • polysaccharides proteins
  • alkanolamines such as beeswax
  • waxes such as beeswax
  • (meth)acrylic polymers such as beeswax
  • perfluoro compounds such as sodium, potassium, zinc, iron or aluminum salts
  • the (b) powder does not comprise synthetic coating which may cause the environmental problems in the same manner as microplastic filler.
  • the amount of the (b) powder(s) in the composition according to the present invention may be 1% by weight or more, preferably 3% by weight or more, more preferably 5% by weight or more, even more preferably 8% by weight or more, and in particular 10% by weight or more, and may be 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, even more preferably 18% by weight or less, and in particular 15% by weight or less, relative to the total weight of the composition.
  • composition according to the present invention comprises (c) at least one cationic polymer.
  • Two or more types of cationic polymer may be used in combination.
  • a single type of cationic polymer or a combination of different types of cationic polymers may be used.
  • a cationic polymer has a positive charge density.
  • the charge density of the cationic polymer may be from 0.01 meq/g to 20 meq/g, preferably from 0.05 tol5 meq/g, and more preferably from 0.1 to 10 meq/g.
  • the cationic polymer is hydrophilic or water soluble. Therefore, the cationic polymer is present in the water phase of the W/O emulsion composition according to the present invention.
  • the molecular weight of the cationic polymer be 500 or more, preferably 1000 or more, more preferably 2000 or more, and even more preferably 5000 or more.
  • molecular weight means a number average molecular weight.
  • the cationic polymer may have at least one positively chargeable and/or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group, and a pyridyl group.
  • the cationic polymer may be a homopolymer or a copolymer.
  • copolymer is understood to mean both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers, such as terpolymers obtained from three kinds of monomers.
  • the cationic polymer may be selected from natural and synthetic cationic polymers.
  • Nonlimiting examples of the cationic polymers are as follows.
  • R 1 and R 2 which may be identical or different, are chosen from hydrogen and alkyl groups comprising from 1 to 6 carbon atoms, for instance, methyl and ethyl groups;
  • R 3 which may be identical or different, is chosen from hydrogen and CH 3 ;
  • the symbols A which may be identical or different, are chosen from linear or branched alkyl groups comprising from 1 to 6 carbon atoms, for example, from 2 to 3 carbon atoms and hydroxyalkyl groups comprising from 1 to 4 carbon atoms;
  • R 4 , R 5 , and R 6 which may be identical or different, are chosen from alkyl groups comprising from 1 to 18 carbon atoms and benzyl groups, and in at least one embodiment, alkyl groups comprising from 1 to 6 carbon atoms; and
  • X is an anion derived from an inorganic or organic acid, such as methosulphate anions and halides, for instance chloride and bromide.
  • the copolymers of family (1) may also comprise at least one unit derived from comonomers which may be chosen from acrylamides, methacrylamides, diacetone acrylamides, acrylamides and methacrylamides substituted on the nitrogen atom with (C 1 -C 4 ) lower alkyl groups, groups derived from acrylic or methacrylic acids and esters thereof, vinyllactams such as vinylpyrrolidone and vinylcaprolactam, and vinyl esters.
  • comonomers which may be chosen from acrylamides, methacrylamides, diacetone acrylamides, acrylamides and methacrylamides substituted on the nitrogen atom with (C 1 -C 4 ) lower alkyl groups, groups derived from acrylic or methacrylic acids and esters thereof, vinyllactams such as vinylpyrrolidone and vinylcaprolactam, and vinyl esters.
  • copolymers of family (1) include, but are not limited to: copolymers of acrylamide and of dimethylaminoethyl methacrylate quatemized with dimethyl sulphate or with a dimethyl halide, copolymers of acrylamide and of methacryloyloxyethyltrimethylammonium chloride described, for example, in European Patent Application No. 0080976, copolymers of acrylamide and of methacryloyloxyethyltrimethylammonium methosulphate, quatemized or nonquatemized vinylpyrrolidone/dialkylaminoalkyl acrylate or methacrylate copolymers, described, for example, in French Patent Nos.
  • dimethylaminoethyl methacrylate/vinylcaprolactam/vinylpyrrolidone terpolymers vinylpyrrolidone/methaciylamidopropyldimethylamine copolymers, quatemized vinylpyrrolidone/dimethylaminopropylmethacrylamide copolymers, and crosslinked methacryloyloxy(C 1 -C 4 )alkyltri(C 1 -C 4 )alkyl ammonium salt polymers such as the polymers obtained by homopolymerization of dimethylaminoethyl methacrylate quatemized with methyl chloride, or by copolymerization of acrylamide with dimethylaminoethyl methacrylate quatemized with methyl chloride, the homopolymerization or copolymerization being followed by crosslinking with a compound containing an olefmic unsaturation, for example, methylenebisacryl
  • copolymers of family (1) have a unit derived from vinylpyrrolidone. More preferably, copolymers of family (1) have at least one pendent ring structure derived from vinylpyrrolidone. On the other hand, it is preferable that the copolymers of family ( 1 ) comprise no ring structure in the backbone of the polymer.
  • copolymers of family (1) having vinylpyrrolidone units can be selected from:
  • the copolymers comprising vinylpyrrolidone units and dimethylaminoethyl methacrylate units, for example: vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer (20/80 by weight) sold under the trade name Copolymer 845 by the company I.S.P., vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers quatemized with diethyl sulphate; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer quatemized with diethyl sulphate, sold under the trade names Gafquat 734, 755, 755S and 755L by the company I.S.P., vinylpyrrolidone/dimethylaminoethyl methacrylate/hydrophilic poly
  • vinylpyrrolidone/dimethylaminoethyl methacrylate/vinylcaprolactam copolymers for example, vinylpyrrolidone/dimethylaminoethyl methacrylate/vinylcaprolactam copolymer sold under the trade name Gaffix VC713 by the company I. S .P;
  • the copolymers comprising vinylpyrrolidone units and methacrylamidopropyltrimethylammonium (MAPTAC) units, for example: vinylpyrrolidone/methacrylamidopropyltrimethylammonium copolymers; for example, vinylpyrrolidone/MAPTAC copolymer sold under the trade names Gafquat ACP 1011 and Gafquat HS100 by the company I.S.P., and - vinylpyrrolidone/methacrylamidopropyltrimethylammonium/vinylcaprolactam terpolymers; for example, vinylpyrrolidone/MAPTAC/vinylcaprolactam terpolymer sold under the trade names Polymer ACP 1059, 1060 and 1156 by the company I.S.P.; and
  • vinylpyrrolidone/methylvinylimidazolium chloride copolymers for example, vinylpyrrolidone/methylvinylimidazolium chloride copolymer sold under the trade names Luviquat FC370, FC550, FC905 and HM552 by the company BASF,
  • vinylpyrrolidone/methylvinylimidazolium chloride/vinylimidazole copolymers for example, vinylpyrrolidone/methylvinylimidazolium chloride/vinylimidazole copolymer sold under the trade name Luviquat 8155 by the company BASF, and
  • vinylpyrrolidone/methylvinylimidazolium methosulphate copolymers for example, vinylpyrrolidone/methylvinylimidazolium methosulphate copolymer sold under the trade name Luviquat MS370 by the company BASF.
  • the copolymers of family (1) be chosen from the copolymer comprising vinylpyrrolidone units and dimethylaminoethyl methacrylate units, more preferably chosen from vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers quatemized with diethyl sulphate, and even more preferably Polyquatemium-11.
  • Cationic cellulose derivatives such as cellulose ether derivatives comprising quaternary ammonium groups described, for example, in French Patent No. 1 492 597, such as the polymers sold under the names "JR" (JR 400, JR 125, JR 30M) or "LR” (LR 400, LR 30M) by the company Union Carbide Corporation. These polymers are also defined in the CTFA dictionary as quaternary ammoniums of hydroxyethylcellulose that have reacted with an epoxide substituted with a trimethylammonium group.
  • the cationic cellulose derivatives be quatemized hydroxyethyl celluloses modified with at least one quaternary ammonium group comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
  • the alkyl radicals borne by the quaternary ammonium group may preferably contain from 8 to 30 carbon atoms, especially from 10 to 30 carbon atoms.
  • the aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
  • the cationic cellulose derivatives may comprise at least one quaternary ammonium group including at least one C8-C30 hydrocarbon group.
  • Examples of quatemized alkylhydroxyethylcelluloses containing C 8 -C 30 fatty chains that may be mentioned include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C12 alkyl) and Quatrisoft LM-X 529-8 (C18 alkyl) or Softcat Polymer SL100, Softcat SX-1300X, Softcat SX-1300H, Softcat SL-5, Softcat SL-30, Softcat SL-60 , Softcat SK-MH, Softcat SX-400X, Softcat SX-400H, SoftCat SK-L, Softcat SK-M, and Softcat SK-H, sold by the company Amerchol and the products Crodacel QM, Crodacel, QL (Cl 2 alkyl) and Crodacel QS (Cl 8 alkyl) sold by the company Croda.
  • Quatrisoft LM 200 Quatrisoft LM-
  • the cationic polymer be selected from the group consisting of Polyquatemium- 24, Polyquatemium-67 and mixtures thereof. Polyquatemium-67 is most preferable.
  • cationic cellulose derivatives could also be chosen among cationic cellulose ether(s), comprising from 4000 to 10000 anhydroglucose units, said anhydroglucose units being substituted with at least:
  • R4 and R5 represent, independently of one another, a methyl or ethyl group
  • R6 represents a linear or branched C 8 -C 24 alkyl group or an aralkyl group in which the linear or branched alkyl part is C 8 -C 24 ,
  • R9 represents a divalent group which allows the attachment to the anhydroglucose group and which is chosen from -(B) q -CH 2 -CHOH-CH 2 - and -CH 2 CH 2 -, q denoting 0 or 1 ,
  • X 2 ' represents an anion
  • R 1 , R 2 and R 3 represent, independently of one another, a methyl or ethyl group
  • R 8 represents a divalent group which allows the attachment to the anhydroglucose group and which is chosen from -(A) p -CH 2 -CHOH-CH 2 - and -CH 2 CH 2 -, p denoting 0 or 1 ,
  • the substituent (i) of formula [R 4 R 5 R 6 R 9 N + ](X2-) is present at an average of from 0.0003 to 0.08 mol, per mole of anhydroglucose units.
  • the cationic cellulose ethers that can be used in the compositions according to the present invention are preferably hydroxyethyl celluloses or hydroxypropyl celluloses.
  • the cationic cellulose ethers that can be used in the compositions according to the present invention preferably comprise more than 4500, advantageously more than 5000, and more preferably more than 6000 anhydroglucose units.
  • the cationic cellulose ethers that can be used in the compositions according to the present invention comprise up to 9000, and more preferably up to 8000 anhydroglucose units.
  • the cationic cellulose ethers that can be used in the compositions according to the present invention are formed from at least one unit (IV) and at least one of the following units (I), (II) and (III): with the proviso that: the total number of units (I)+(II)+(III)+(IV) is between 4000 and 10000; the [(III)+(IV)]/[(I)+(II)+(III)+(IV)] ratio ranges from 0.0003 to 0.8; the [(II)+(IV)]/[(I)+(II)+(III)+(IV)] ratio ranges from 0.02 to 0.9; the integers n and n', independently of one another, range from 0 to 5;
  • R 1 , R 2 , R 3 , R 4 and R 5 represent, independently of one another, a methyl or ethyl group
  • R 6 represents a linear or branched C 8 -C 24 , preferably C 10 -C 24 , more preferably C 12 -C 24 and better still C 12 -C 15 , an lkyl group or an aralkyl group in which the linear or branched alkyl part is C 8 -C 24 ;
  • X 1 - and X 2 - represent anions preferably chosen, independently of one another, from phosphate, nitrate, sulphate and halide (Cl-, Br-, F-, G)- ions.
  • the cationic cellulose ethers that can be used in the compositions according to the present invention are formed from at least one unit (IV) and at least one of the units (I), (II) or (III) above, in which R 6 is a linear dodecyl group.
  • the cationic cellulose ethers that are particularly preferred are the polymers of SL-60 and SL-100 type.
  • Cationic cellulose derivatives such as cellulose copolymers and cellulose derivatives grafted with a water-soluble monomer of quaternary ammonium, and described, for example, in U.S. Pat. No. 4,131,576, such as hydroxyalkylcelluloses, for instance, hydroxymethyl-, hydroxyethyl-, and hydroxypropylcelluloses grafted, for example, with a salt chosen from methacryloylethyltrimethylammonium, methacrylamidopropyltrimethylammonium, and dimethyldiallylammonium salts.
  • Non-cellulose-based cationic polysaccharides described in U.S. Pat. Nos. 3,589,578 and 4,031,307 such as guar gums comprising cationic trialkylammonium groups, cationic hyaluronic acid, and dextran hydroxypropyl trimonium chloride.
  • Guar gums modified with a salt, for example, the chloride, of 2,3-epoxypropyltrimethylammonium (guar hydroxypropyltrimonium chloride) may also be used.
  • Such products are sold, for instance, under the trade names JAGUAR® Cl 3 S, JAGUAR® Cl 5, JAGUAR® Cl 7, and JAGUAR® Cl 62 by the company MEYHALL.
  • Polymers comprising piperazinyl units and divalent alkylene or hydroxyalkylene groups comprising straight or branched chains, optionally interrupted with at least one entity chosen from oxygen, sulphur, nitrogen, aromatic rings, and heterocyclic rings, and also the oxidation and/or quaternization products of these polymers.
  • Such polymers are described, for example, in French Patent Nos. 2 162025 and 2280361.
  • Water-soluble polyamino amides prepared, for example, by polycondensation of an acidic compound with a polyamine; these polyamino amides possibly being crosslinked with an entity chosen from epihalohydrins; diepoxides; dianhydrides; unsaturated dianhydrides; bisunsaturated derivatives; bishalohydrins; bisazetidiniums; bishaloacyidiamines; bisalkyl halides; oligomers resulting from the reaction of a difunctional compound which is reactive with an entity chosen from bishalohydrins, bisazetidiniums, bishaloacyldiamines, bisalkyl halides, epihalohydrins, diepoxides, and bisunsaturated derivatives; the crosslinking agent being used in an amount ranging from 0.025 to 0.35 mol per amine group of the polyamino amide; these polyamino amides optionally being alkylated or, if they comprise at least one
  • difunctional agents for example, adipic acid/dialkylaminohydroxyalkyldialkylenetriamine polymers in which the alkyl group comprises from 1 to 4 carbon atoms, such as methyl, ethyl, and propyl groups, and the alkylene group comprises from 1 to 4 carbon atoms, such as an ethylene group.
  • adipic acid/dialkylaminohydroxyalkyldialkylenetriamine polymers in which the alkyl group comprises from 1 to 4 carbon atoms, such as methyl,
  • the molar ratio of the polyalkylene polyamine to the dicarboxylic acid may range from 0.8: 1 to 1.4: 1 ; the polyamino amide resulting therefrom being reacted with epichlorohydrin in a molar ratio of epichlorohydrin relative to the secondary amine group of the polyamino amide ranging from 0.5:1 to 1.8:1.
  • Such polymers are described, for example, in U.S. Pat. Nos. 3,227,615 and 2,961 ,347.
  • Cyclopolymers of alkyldiallylamine and cyclopolymers of dialkyldiallyl-ammonium comprising, as the main constituent of the chain, at least one unit chosen from units of formulas (la) and (lb): wherein: k and t, which may be identical or different, are equal to 0 or 1 , the sum k+t being equal to 1 ; R 12 is chosen from hydrogen and methyl groups; R 10 and Rn, which may be identical or different, are chosen from alkyl groups comprising from 1 to 6 carbon atoms, hydroxyalkyl groups in which the alkyl group comprises, for example, from 1 to 5 carbon atoms, and lower (C 1 -C 4 )amidoalkyl groups, or R 10 and R 11 may form, together with the nitrogen atom to which they are attached, heterocyclic groups such as piperidinyl and morpholinyl; and
  • Y' is an anion such as bromide, chloride, acetate, borate, citrate, tartrate, bisulphate, bisulphite, sulphate, and phosphate.
  • R 10 and R 11 which may be identical or different, are chosen from alkyl groups comprising from 1 to 4 carbon atoms.
  • polymers examples include, but are not limited to, (co)polydiallyldialkyl ammonium chloride such as the dimethyidiallylammonium chloride homopolymer sold under the name "MERQUAT® 100" by the company CALGON (and its homologues of low weight-average molecular mass) and the copolymers of diallyldimethylammonium chloride and of acrylamide sold under the name "MERQUAT® 550".
  • Quaternary diammonium polymers comprising at least one repeating unit of formula (II): wherein: R 13 , R 14 , R 15 , and R 16 , which may be identical or different, are chosen from aliphatic, alicyclic, and arylaliphatic groups comprising from 1 to 20 carbon atoms and lower hydroxyalkyl aliphatic groups, or alternatively Rn, Rn, Rn, and Rn may form, together or separately, with the nitrogen atoms to which they are attached, heterocycles optionally comprising a second heteroatom other than nitrogen, or alternatively R 13 , R 14 , R 15 , and R 16 , which may be identical or different, are chosen from linear or branched C 1 -C 6 alkyl groups substituted with at least one group chosen from nitrile groups, ester groups, acyl groups, amide groups, -CO-O- R 17 -E groups, and -CO-NH- R 17 -E groups, wherein Rn is an alky
  • a 1 and B 1 which may be identical or different, are chosen from polymethylene groups comprising from 2 to 20 carbon atoms, which may be linear or branched, saturated or unsaturated, and which may comprise, linked or intercalated in the main chain, at least one entity chosen from aromatic rings, oxygen, sulphur, sulphoxide groups, sulphone groups, disulphide groups, amino groups, alkylamino groups, hydroxyl groups, quaternary ammonium groups, ureido groups, amide groups, and ester groups, and
  • X- is an anion derived from an inorganic or organic acid
  • a 1 , R 13 , and R 15 may form, together with the two nitrogen atoms to which they are attached, a piperazine ring; if A 1 is chosen from linear or branched, saturated or unsaturated alkylene or hydroxyalkylene groups, Bi may be chosen from:
  • E' is chosen from: a) glycol residues of formula -O-Z-O-, wherein Z is chosen from linear or branched hydrocarbon- based groups and groups of the following formulas: -(CH 2 -CH 2 -O) X -CH 2 -CH 2 -
  • x and y which may be identical or different, are chosen from integers ranging from 1 to 4, which represent a defined and unique degree of polymerization, and numbers ranging from 1 to 4, which represent an average degree of polymerization; b) bis-secondary diamine residue such as piperazine derivatives; c) bis-primary diamine residues of formula -NH-Y-NH-, wherein Y is chosen from linear or branched hydrocarbon-based groups and the divalent group -CH 2 -CH 2 -S-S-CH 2 -CH 2 -; and d) ureylene groups of formula -NH-CO-NH-.
  • X- is an anion such as chloride or bromide.
  • Non-limiting examples of such polymers include those comprising at least one repeating unit of formula (III): wherein R 13 , R 14 , R 15 , and R 16 , which may be identical or different, are chosen from alkyl and hydroxyalkyl groups comprising from 1 to 4 carbon atoms, n and p, which may be identical or different, are integers ranging from 2 to 20, and X ' is an anion derived from an inorganic or organic acid.
  • Polyquatemary ammonium polymers comprising units of formula (IV) : wherein: R 18 , R 19 , R 20 , and R 21 , which may be identical or different, are chosen from hydrogen, methyl groups, ethyl groups, propyl groups, b-hydroxyethyl groups, b-hydroxypropyl groups, - CH 2 CH 2 (OCH 2 CH 2 ) p OH groups, wherein p is chosen from integers ranging from 0 to 6, with the proviso that R 18 , R 19 , R 20 , and R 21 are not simultaneously hydrogen, r and s, which may be identical or different, are chosen from integers ranging from 1 to 6, q is chosen from integers ranging from 0 to 34,
  • X- is an anion such as a halide
  • A is chosen from radicals of dihalides and -CH 2 -CH 2 -O-CH 2 -CH 2 -. Such compounds are described, for instance, in European Patent Application No. 0 122324.
  • Suitable cationic polymers include, but are not limited to, cationic proteins and cationic protein hydrolysates, polyalkyleneimines, such as polyethyleneimines, polymers comprising units chosen from vinylpyridine and vinylpyridinium units, condensates of polyamines and of epichlorohydrin, quaternary polyureylenes, and chitin derivatives.
  • the at least one cationic polymer is chosen from cellulose ether derivatives comprising quaternary ammonium groups, such as the products sold under the name "JR 400" by the company UNION CARBIDE CORPORATION, cationic cyclopolymers, for instance, the homo-polymers and copolymers of dimethyldiallylammonium chloride sold under the names MERQUAT® 100, MERQUAT® 550, and MERQUAT® S by the company CALGON, guar gums modified with a 2,3-epoxypropyltrimethylammonium salt, and quaternary polymers of vinylpyrrolidone and of vinylimidazole.
  • quaternary ammonium groups such as the products sold under the name "JR 400" by the company UNION CARBIDE CORPORATION
  • cationic cyclopolymers for instance, the homo-polymers and copolymers of dimethyldiallylammonium chloride sold under the names MERQUAT® 100, MER
  • (co)polyamines which may be homopolymers or copolymers, with a plurality of amino groups.
  • the amino group may be a primary, secondary, tertiary or quaternary amino group.
  • the amino group may be present in a polymer backbone or a pendent group, if present, of the (co)polyamines.
  • (co)polyamines examples include chitosan, (co)polyallylamines, (co)polyvinylamines, (co)polyanilines, (co)polyvinylimidazoles,
  • (co)polydimethylaminoethylenemethacrylates (co)polyvinylpyridines such as (co)poly-l-methyl- 2-vinylpyridines, (co)polyimines such as (co)polyethyleneimines, (co)polypyridines such as (co)poly(quatemary pyridines), (co)polybiguanides such as (co)polyaminopropyl biguanides, (co)polylysines, (co)polyomithines, (co)polyarginines, (co)polyhistidines, aminodextrans, aminocelluloses, amino(co)polyvinylacetals, and salts thereof.
  • polylysine As the (co)polyamines, it is preferable to use (co)polylysines.
  • Polylysine is well known. Polylysine can be a natural homopolymer of L-lysine that can be produced by bacterial fermentation. For example, polylysine can be e-Poly-L- lysine, typically used as a natural preservative in food products. Polylysine is a polyelectrolyte which is soluble in polar solvents such as water. Polylysine is commercially available in various forms, such as poly D-lysine and poly L-lysine. Polylysine can be in salt and/or solution form.
  • cationic polyaminoacids which may be cationic homopolymers or copolymers, with a plurality of amino groups and carboxyl groups.
  • the amino group may be a primary, secondary, tertiary or quaternary amino group.
  • the amino group may be present in a polymer backbone or a pendent group, if present, of the cationic polyaminoacids.
  • the carboxyl group may be present in a pendent group, if present, of the cationic polyaminoacids.
  • cationic polyaminoacids mention may be made of cationized collagen, cationized gelatin, steardimonium hydroxypropyl hydrolyzed wheat protein, cocodimonium hydroxypropyl hydrolyzed wheat protein, hydroxypropyltrimonium hydrolyzed conchiolin protein, steardimonium hydroxypropyl hydrolyzed soy protein, hydroxypropyltrimonium hydrolyzed soy protein, cocodimonium hydroxypropyl hydrolyzed soy protein, and the like.
  • the cationic polymer be selected from the group consisting of cyclopolymers of alkyldiallylamine and cyclopolymers of dialkyldiallylammonium such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as (co)polylysines, cationic (co)polyaminoacids such as cationized collagen, and salts thereof.
  • the cationic polymer be a polyquatemium polymer or a polymeric quaternary ammonium salt.
  • Polymeric quaternary ammonium salts are cationic polymers comprising at least one quatemized nitrogen atom. Mention may in particular be made, as polymeric quaternary ammonium salts, of the Polyquatemium products (CTFA name), which contribute mainly to the quality of the foam and the feeling of the skin after use, in particular the feeling of the skin after use. These polymers can preferably be chosen from the following polymers:
  • Polyquatemium-5 such as the product Merquat 5 sold by Nalco;
  • Polyquatemium-6 such as the product Salcare SC 30 sold by BASF and the product Merquat 100 sold by Nalco;
  • Polyquatemium-7 such as the products Merquat S, Merquat 2200, Merquat 7SPR, and Merquat 550 sold by Nalco and the product Salcare SC 10 sold by BASF;
  • Polyquatemium- 16 such as the products Luviquat FC905, Luviquat FC370, Luviquat HM552 and Luviquat FC550 sold by BASF;
  • Polyquatemium-28 such as the product Styleze CC10 sold by ISP;
  • Polyquatemium-44 such as the product Luviquat Care sold by BASF;
  • Polyquatemium-46 such as the product Luviquat Hold sold by BASF;
  • Polyquatemium-47 such as the product Merquat 2001 sold by Nalco
  • Polyquatemium-67 such as the product Softcat sold by Amerchol.
  • the amount of the cationic polymer(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, and may be 5% by weight or less, preferably 3% by weight or less, more preferably 1 % by weight or less, and even more preferably 0.5% by weight or less, relative to the total weight of the composition.
  • composition according to the present invention comprises (d) at least one oil.
  • Two or more oils may be used in combination.
  • a single type of oil or a combination of different types of oils may be used.
  • oil means a fatty compound or substance which is in the form of a liquid or a paste (nonsolid) at room temperature (25°C) under atmospheric pressure (760 mmHg).
  • oils those generally used in cosmetics can be used alone or in combination thereof. These oils may be volatile or non-volatile.
  • the oil forms an oil phase of the W/O emulsion composition according to the present invention.
  • the oil may be a non-polar oil such as a hydrocarbon oil, a silicone oil, or the like; a polar oil such as a plant or animal oil and an ester oil or an ether oil; or a mixture thereof.
  • the oil may be selected from the group consisting of oils of plant or animal origin, synthetic oils, silicone oils, hydrocarbon oils, fatty alcohols and fatty acids.
  • plant oils mention may be made of, for example, linseed oil, camellia oil, macadamia nut oil, com oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil, and mixtures thereof.
  • animal oils mention may be made of, for example, squalene and squalane.
  • synthetic oils mention may be made of alkane oils such as isododecane and isohexadecane, ester oils, ether oils, and artificial triglycerides.
  • the ester oils are preferably liquid esters of saturated or unsaturated, linear or branched C1-C26 aliphatic monoacids or polyacids and of saturated or unsaturated, linear or branched C1-C26 aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10.
  • esters of monoalcohols Preferably, for the esters of monoalcohols, at least one from among the alcohol and the acid from which the esters of the present invention are derived is branched.
  • monoesters of monoacids and of monoalcohols mention may be made of ethyl palmitate, ethyl hexyl palmitate, isopropyl palmitate, dicaprylyl carbonate, alkyl myristates such as isopropyl myristate or ethyl myristate, isocetyl stearate, 2-ethylhexyl isononanoate, isononyl isononanoate, isodecyl neopentanoate, and isostearyl neopentanoate.
  • ether oils mention may be made of, for example, ether oils with a short hydrocarbon chain or chains, such as dicaprylyl ether.
  • artificial triglycerides mention may be made of, for example, capryl caprylyl glycerides, glyceryl trimyristate, glyceryl tripalmitate, glyceryl trilinolenate, glyceryl trilaurate, glyceryl tricaprate, glyceryl tricaprylate, glyceryl tri(caprate/caprylate), and glyceryl tri(caprate/caprylate/linolenate).
  • capryl caprylyl glycerides glyceryl trimyristate, glyceryl tripalmitate, glyceryl trilinolenate, glyceryl trilaurate, glyceryl tricaprate, glyceryl tricaprylate, glyceryl tri(caprate/caprylate), and glyceryl tri(caprate/caprylate/linolenate).
  • silicone oils mention may be made of, for example, linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, and the like; cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, and the like; and mixtures thereof.
  • linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, and the like
  • cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodeca
  • the silicone oil is chosen from liquid polydialkylsiloxanes, especially liquid polydimethylsiloxanes (PDMS, dimethicone) and liquid polyorganosiloxanes comprising at least one aryl group.
  • PDMS liquid polydimethylsiloxanes
  • dimethicone liquid polydimethylsiloxanes
  • liquid polyorganosiloxanes comprising at least one aryl group.
  • These silicone oils may also be organomodified.
  • the organomodified silicones that can be used in accordance with the present invention are silicone oils as defined above and comprise in their structure one or more organofunctional groups attached via a hydrocarbon-based group.
  • Hydrocarbon oils may be chosen from: linear or branched, optionally cyclic, C 6 -C 16 lower alkanes. Examples that may be mentioned include hexane, undecane, dodecane, tridecane, and isoparaffins, for instance isohexadecane, isododecane, and isodecane; linear or branched hydrocarbons containing more than 16 carbon atoms, such as liquid paraffins, liquid petroleum jelly, polydecenes and hydrogenated polyisobutenes such as Parleam®, and squalene; mixtures of alkanes, for example, C9- 12 Alkane, C 10- 13 Alkane, C 13 - 14 Alkane, C 13 - 15 Alkane, C14-17 Alkane, C14-19 Alkane, C15-19 Alkane, C15-23 Alkane, C18-21Alkane, C8-9 Alkane/Cycloalkane, C9-10 Alkane/Cycloal
  • fatty in the fatty alcohol means the inclusion of a relatively large number of carbon atoms. Thus, alcohols which have 4 or more, preferably 6 or more, and more preferably 12 or more carbon atoms are encompassed within the scope of fatty alcohols.
  • the fatty alcohol may be saturated or unsaturated.
  • the fatty alcohol may be linear or branched.
  • the fatty alcohol may have the structure R-OH wherein R is chosen from saturated and unsaturated, linear and branched radicals containing from 4 to 40 carbon atoms, preferably from 6 to 30 carbon atoms, and more preferably from 12 to 20 carbon atoms.
  • R may be chosen from C 12 -C 20 alkyl and C 12 -C 20 alkenyl groups. R may or may not be substituted with at least one hydroxyl group.
  • the fatty alcohol mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, oleyl alcohol, linoleyl alcohol, palmitoleyl alcohol, arachidonyl alcohol, emcyl alcohol, and mixtures thereof. It is preferable that the fatty alcohol be a saturated fatty alcohol.
  • the fatty alcohol may be selected from straight or branched, saturated or unsaturated C6-C30 alcohols, preferably straight or branched, saturated C6-C30 alcohols, and more preferably straight or branched, saturated C 12 -C 20 alcohols.
  • saturated fatty alcohols mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof.
  • cetyl alcohol, stearyl alcohol, octyldodecanol, hexyldecanol, or a mixture thereof (e.g., cetearyl alcohol) as well as behenyl alcohol can be used as a saturated fatty alcohol.
  • the fatty acids that may be used in the composition of the present disclosure may be saturated or unsaturated and comprise from 6 to 30 carbon atoms such as from 9 to 30 carbon atoms. As nonlimiting examples, they may be chosen from myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, and isostearic acid.
  • the amount of the oil(s) in the composition according to the present invention may be 3% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, and in particular 20% by weight or more, and may be 50% by weight or less, preferably 40% by weight or less, more preferably 35% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
  • the composition according to the present invention may comprise at least one cosmetically acceptable hydrophilic organic solvent.
  • the cosmetically acceptable hydrophilic organic solvent(s) may include, for example, substantially linear or branched lower mono-alcohols having from 1 to 8 carbon atoms, such as ethanol, propanol, butanol, isopropanol, and isobutanol; aromatic alcohols, such as benzyl alcohol and phenylethyl alcohol; polyols or polyol ethers, such as propylene glycol, dipropylene glycol, isoprene glycol, butylene glycol, pentylene glycol, glycerine, propanediol, sorbitol, ethylene glycol monomethyl, monoethyl and monobutyl ethers, propylene glycol ethers, such as propylene glycol monomethylether, diethylene glycol alkyl ethers, such as diethylene glycol monoethylether or monobutylether; polyethylene
  • the amount of the cosmetically acceptable hydrophilic organic solvent(s) in the composition according to the present invention may range from 1 to 30% by weight, preferably from 2 to 25% by weight, and more preferably from 3 to 20% by weight, relative to the total weight of the composition.
  • composition according to the present invention may comprise at least one surfactant chosen from amphoteric, anionic, cationic, or nonionic surfactants, used alone or as a mixture.
  • the composition comprises at least one nonionic surfactant.
  • nonionic surfactants usable in the compositions of the invention may include polyethoxylated fatty alcohols or polyglycerolated fatty alcohols, such as the adducts of ethylene oxide with lauryl alcohol, especially those containing from 9 to 50 oxyethylene units (Laureth-9 to Laureth-50 as the INCI names), in particular Laureth-9; esters of polyols and of a fatty acid possessing a saturated or unsaturated chain comprising, for example, from 8 to 24 carbon atoms, and their oxyalkylenated derivatives, that is to say comprising oxyethylene and/or oxypropylene units, such as esters of glycerol and of a C 8 -C 24 fatty acid, and their oxyalkylenated derivatives, in particular polyoxyethylenated glyceryl stearate (mono-, di- and/or tristearate), for example PEG-20 glyceryl triisostearate; esters of sugar and of
  • alkylpolyglycosides as nonionic surfactants, represented by the following general formula (1): R-0-(G) x (l) in which R represents a branched and/or unsaturated alkyl radical comprising from 14 to 24 carbon atoms, G represents a reduced sugar comprising 5 or 6 carbon atoms and x denotes a value ranging from 1 to 10 and preferably from 1 to 4, and G in particular denotes glucose, fructose or galactose.
  • R represents a branched and/or unsaturated alkyl radical comprising from 14 to 24 carbon atoms
  • G represents a reduced sugar comprising 5 or 6 carbon atoms
  • x denotes a value ranging from 1 to 10 and preferably from 1 to 4
  • G in particular denotes glucose, fructose or galactose.
  • This alkyl polyglucoside can be used as a mixture with a coemulsifier, more especially with a fatty alcohol and in particular a fatty alcohol having the same fatty chain as that of the alkyl polyglucoside, that is to say comprising from 14 to 24 carbon atoms and having a branched and/or unsaturated chain, for example isostearyl alcohol when the alkyl polyglucoside is isostearyl glucoside and oleyl alcohol when the alkyl polyglucoside is oleyl glucoside.
  • Use may be made, for example, of the mixture of isostearyl glucoside and isostearyl alcohol, sold under the name Montanov WO 18 by Seppic, and also the mixture of octyldodecanol and octyldodecyl xyloside sold under the name Fludanov 20X by Seppic.
  • the amount of the surfactant(s) in the composition may be from 0.1 to 15% by weight, preferably from 0.5 to 10% by weight, and more preferably from 1 to 5% by weight, relative to the total weight of the composition.
  • composition according to the present invention may comprise at least one thickener. Two or more thickeners can be combined.
  • the thickener may be hydrophilic or lipophilic, and preferably lipophilic.
  • the lipophilic thickener may be in the form of polymer or particles.
  • the lipophilic polymer thickener may be chosen from carboxyvinyl polymers such as the Carbopol products (carbomers) and the Pemulen products (acrylate/C 10-C30-alkyl acrylate copolymer) or polymers having the INCI name "Poly CIO-30 Alkyl Acrylate", such as the Intelimer® products from Air Products, such as the product Intelimer® IPA 13-1, which is a polystearyl acrylate, or the product 30 Intelimer® IPA 13-6 which is a behenyl polymer.
  • carboxyvinyl polymers such as the Carbopol products (carbomers) and the Pemulen products (acrylate/C 10-C30-alkyl acrylate copolymer) or polymers having the INCI name "Poly CIO-30 Alkyl Acrylate", such as the Intelimer® products from Air Products, such as the product Intelimer® IPA 13-1, which is a polystearyl acrylate, or the product 30 Inteli
  • the lipophilic thickener according to the present invention may be chosen from:
  • organomodified clays which are clays treated with compounds chosen especially from quaternary amines and tertiary amines.
  • Organomodified clays that may be mentioned include organomodified bentonites, such as the product sold under the name Bentone 34 by the company Rheox, and organomodified hectorites such as the products sold under the names Bentone 27 and Bentone 38 by the company Rheox.
  • modified clays such as modified magnesium silicate (Bentone gel ® VS38 from Rheox), modified hectorites such as hectorite modified with a C 10 to C22 fatty acid ammonium chloride, for instance hectorite modified with distearyldimethylammonium chloride (disteardimonium hectorite) such as the product sold under the name Bentone 38VCG by the company Elementis or the product sold under the name Bentone 38 CE by the company Rheox, or the product sold under the name Bentone Gel ® V5 5V by the company Elementis, or the product sold under the name Bentone gel ® ISD V by the company Elementis;
  • modified clays such as modified magnesium silicate (Bentone gel ® VS38 from Rheox), modified hectorites such as hectorite modified with a C 10 to C22 fatty acid ammonium chloride, for instance hectorite modified with distearyldimethylammonium chloride (dist
  • the amount of the thickener(s) in the composition may be from 0.1 to 10% by weight, preferably from 0.2 to 5% by weight, and more preferably from 0.3 to 3% by weight, relative to the total weight of the composition.
  • composition according to the present invention may comprise at least one inorganic UV filter. Two or more inorganic UV filters can be combined.
  • the inorganic UV filter used for the present invention may be active in the UV-A and/or UV-B region.
  • the inorganic UV filter may be hydrophilic and/or lipophilic.
  • the inorganic UV filter is preferably insoluble in solvents such as water and ethanol, commonly used in cosmetics.
  • the inorganic UV filter used for the present invention is different from the (b) powder of the present invention.
  • the inorganic UV filter be in the form of a fine particle such that the mean (primary) particle diameter thereof ranges from 1 nm to 150 nm, preferably 5 nm to 100 nm, and more preferably 10 nm to 50 nm.
  • the mean (primary) particle size or mean (primary) particle diameter here is an arithmetic mean diameter.
  • the inorganic UV filter can be selected from the group consisting of metal oxides which may or may not be coated, and mixtures thereof.
  • the inorganic UV filters may be selected from pigments (mean size of the primary particles: generally from 5 nm to 50 nm, preferably from 10 nm to 50 nm) formed of metal oxides, such as, for example, pigments formed of titanium oxide (amorphous or crystalline in the rutile and/or anatase form), iron oxide, zinc oxide, zirconium oxide or cerium oxide, which are all UV photoprotective agents that are well known per se.
  • the inorganic UV filters may be selected from titanium oxide, zinc oxide, and more preferably titanium oxide.
  • the inorganic UV filter may or may not be coated.
  • the inorganic UV filter may have at least one coating.
  • the coating may comprise at least one compound selected from the group consisting of alumina, silica, aluminum hydroxide, silicones, silanes, fatty acids or salts thereof (such as sodium, potassium, zinc, iron, or aluminum salts), fatty alcohols, lecithin, amino acids, polysaccharides, proteins, alkanolamines, waxes such as beeswax, (meth)acrylic polymers, organic UV filters, and (per)fluoro compounds.
  • the silicones in the coating(s) may be organosilicon polymers or oligomers comprising a linear or cyclic and branched or cross-linked structure, of variable molecular weight, obtained by polymerization and/or polycondensation of suitable functional silanes and essentially composed of repeated main units in which the silicon atoms are connected to one another via oxygen atoms (siloxane bond), optionally substituted hydrocarbon radicals being connected directly to said silicon atoms via a carbon atom.
  • the silicones used for the coating(s) can preferably be selected from the group consisting of alkylsilanes, polydialkylsiloxanes, and polyalkylhydrosiloxanes. More preferably still, the silicones are selected from the group consisting of octyltrimethylsilanes, polydimethylsiloxanes, and polymethylhydrosiloxanes.
  • the inorganic UV filters made of metal oxides may, before their treatment with silicones, have been treated with other surfacing agents, in particular, with cerium oxide, alumina, silica, aluminum compounds, silicon compounds, or their mixtures.
  • the amount of the inorganic UV filter(s) in the composition may be from 0.5% by weight or more, preferably 1 % by weight or more, and more preferably 1.5% by weight or more, and 15% by weight or less, preferably 10% by weight or less, more preferably 7% by weight or less, and even more preferably 5% weight or less, relative to the total weight of the composition.
  • composition according to the present invention can comprise water.
  • the amount of water in the composition may be from 2% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, and 60% by weight or less, preferably 50% by weight or less, more preferably 40% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
  • compositions according to the present invention may also contain various adjuvants conventionally used in compositions for sun care products, which may be selected from a physiologically acceptable medium, anionic, non-ionic, amphoteric or zwitterionic polymers or mixtures thereof, antioxidants, neutralizing agents, alkaline agents, such as sodium hydroxide, sequestering agents, such as trisodium ethylenediamine disuccinate, disodium EDTA, and phytin acid, buffers, such as tromethamine, fragrances, emollients, dispersing agents, dyes and/or pigments, film-forming agents and/or thickeners, ceramides, preservatives, such as phenoxy ethanol and caprylyl glycol, co-preservatives and opacifying agents.
  • adjuvants conventionally used in compositions for sun care products, which may be selected from a physiologically acceptable medium, anionic, non-ionic, amphoteric or zwitterionic polymers or mixtures thereof,
  • the adjuvants may be present in the composition of the present invention in an amount preferably ranging from 0.01% to 30% by weight, more preferably from 0.1% to 20% by weight, and even more preferably from 0.5% to 10% by weight, relative to the total weight of the composition.
  • composition according to the present invention comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, more preferably 1% by weight or less, even more preferably 0.05% by weight or less, and in particular 0.01% by weight, relative to the total weight of the composition.
  • composition according to the present invention is free of microplastic filler.
  • the composition according to the present invention may be intended for use as a cosmetic topical composition.
  • the composition according to the present invention may be intended for application onto a keratinous substance.
  • Keratinous substance here means a material containing keratin as a main constituent element, and examples thereof include the skin, scalp, nails, lips, hair, and the like.
  • the composition according to the present invention may be a skin sun care cosmetic composition for protecting skin from UV rays.
  • the viscosity of the composition according to the present invention is not particularly limited.
  • the viscosity of the composition according to the present invention ranges from 1 to 1,000,000 mm 2 /s, more preferably from 2 mm 2 /s to 500,000 mm 2 /s, and even more preferably from 5 mm 2 /s to 100,000 mm 2 /s at 25°C.
  • the viscosity of the composition according to the present invention can be measured using a Poiseuille rheometer, at a temperature of 25 °C, according to standard ASTM-D445-97.
  • composition according to the present invention can be prepared by mixing ingredients (a) to (d), as essential ingredients, as well as optional ingredient(s), as explained above.
  • the present invention also relates to: a cosmetic process for a keratin substrate, such as skin, comprising applying to the keratin substrate the composition according to the present invention.
  • the composition according to the present invention may preferably be used as a cosmetic composition.
  • the cosmetic composition may be a sun care composition for protecting keratinous substances, such as skin, from UV rays.
  • the cosmetic process here means a non-therapeutic cosmetic method for caring for and/or making up the surface of a keratin substrate such as skin.
  • the present invention relates to a cosmetic process for protecting keratinous substances from UV radiation, comprising, at least one step of applying the composition according to the present invention to the keratinous substance, such as skin.
  • Each of the W/O emulsion compositions according to Examples 1 and 2 (Ex. 1 and Ex. 2) and Comparative Examples 1 to 8 (Comp. Ex. 1 to Comp. Ex. 8) was prepared by mixing the ingredients listed in the following Tables 1 and 2.
  • the W/O emulsion compositions were prepared by first mixing the ingredients of the “oil phase” and the ingredients of the “water phase”, then adding “powder” ingredients and ethanol to the mixture, and then mixing it until it became homogenous.
  • the numerical values in parentheses in the powder ingredients indicate average particle size of the powder ingredients. Titanium dioxide and zinc oxide in the oil phase were used as inorganic UV filters.
  • the numerical values for the amounts of the ingredients are all based on “% by weight” as active raw materials.
  • the composition After applying 1 g of each of the compositions on the back side of the hand, the composition was dried for 1 to 2 minutes. Subsequently, after putting the hand into a beaker containing 2L of tap water for 1 minute, a change in the surface of the water was observed with the naked eye. The change in skin color was evaluated for each composition under the following criteria.
  • the obtained emulsion compositions in a 100 mL were kept at 25°C for 24 hours after they were manufactured. The appearance of each sample was then observed with the naked eye. The stability property was evaluated for each composition under the following criteria.
  • the W/O emulsion composition according to Examples 1 and 2 which include a combination of at least one lipophilic organic UV filter, at least one powder other than microplastic filler, and at least one cationic polymer exerted an improved water resistance property, fresh sensation on application, and a good stability.
  • the composition according to Comparative Example 1 which does not include any powder other than microplastic filler but includes microplastic fillers, did not show a good water resistance property because of the inferior water clearness result.
  • the W/O emulsion composition according to the present invention is very preferable as a sun care cosmetic composition.

Abstract

The present invention relates to a W/O emulsion composition comprising: (a) at least one lipophilic organic UV filter, (b) at least one powder other than microplastic filler, (c) at least one cationic polymer, and (d) at least one oil, wherein the composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.

Description

DESCRIPTION
TITLE OF INVENTION SUNSCREEN W/O EMULSION
TECHNICAL FIELD
The present invention relates to a W/O emulsion composition, in particular a sun care composition in the form of a W/O emulsion, for a keratinous substance such as skin.
BACKGROUND ART
Sun care products are widely used in order to protect keratinous substances, in particular skin, from the damage caused by UV radiation. Among sun care products, W/O emulsion sun care compositions are widely distributed since they are in general water resistant and thus can be retained on the surface of the skin even after exposed to water or sweat.
For example, JP-A-2009-191033 discloses a water-in-oil type sunblock cosmetic including: (A) a partially crosslinked polyester modified organopolysiloxane; (B) an organic titanate-treated fine particulate zinc oxide and/or an organic titanate-treated fine particulate titanium oxide; (C) a silicone oil; (D) one or more oily agents selected from glyceryl trioctanoate, glyceryl tri(capryl- capric acid), and dioctanoic acid neopentyl. In recent years, the polluteing of the ocean environment and the destroyuction of the marine- ecosystem by microplastics have become a big concern. Therefore, cosmetic products including a small amount of microplastic fillers or not including microplastic fillers have been proposed.
For example, JP-A-2020-97552 discloses a cosmetic preparation for concavo-convex compensation containing the following components (a) to (d): (a) 6 to 10 wt.% of fumed hydrophobic silica; (b) 5 to 20 wt.% of octamethyltrisiloxane and/or decamethyltetrasiloxane; (c) batyl alcohol; and (d) 10 to 30 wt.% of powders other than (a) that contain no microplastic beads, the cosmetic preparation for concavo-convex compensation containing no microplastic beads. In sun care cosmetic products, organic UV filters are widely used to impart a UV protecting property to sun care compositions. However, the use of organic UV filters may have a negative impact such as imparting oily, greasy, and sticky sensations during application. Also, oils in W/O emulsion may cause oily, greasy, and sticky sensations on application. Furthermore, there is a problem in that W/O emulsions may not have sufficient stability to maintain their emulsion form over time.
Therefore, there is a demand for W/O emulsion compositions comprising organic UV filters, which are well resistant to water resistant, impart an improved texture, such as a fresh sensation, and have good stability without causing phase separation over time. Furthermore, sun care cosmetic compositions which do not contain microplastic fillers are also desired as environmentally-sustainable products.
DISCLOSURE OF INVENTION An objective of the present invention is to provide a water-resistant W/O emulsion composition having an improved texture, such as a fresh sensation and having good stability, and not comprising microplastic fillers.
The above objective of the present invention can be achieved by a W/O emulsion composition, comprising:
(a) at least one lipophilic organic UV filter,
(b) at least one powder other than microplastic filler,
(c) at least one cationic polymer, and
(d) at least one oil, wherein the composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.
The (b) powder may be selected from talc, mica, silica, silica silicate, magnesium aluminum silicate, kaolin, bentone, calcium carbonate, magnesium hydrogen carbonate, hydroxyapatite, boron nitride, fluorphlogopite, sericite, calcinated talc, calcinated mica, calcinated sericite, synthetic mica, perlite, lauroyl lysine, metal soap, bismuth oxychloride, barium sulfate, magnesium carbonate, and natural polymer powders, such as polysaccharide powders, for example, starch, cellulose powder, and mixtures thereof.
The average particle size of the (b) powder may be 50 pm or less, preferably 20 pm or less, and more preferably 15 pm or less, and may be 0.2 pm or more, preferably 0.5 pm or more, and more preferably 1 pm or more.
The (c) cationic polymer may be selected from quatemized hydroxyethyl celluloses modified with at least one quaternary ammonium group comprising at least one fatty chain
The (c) cationic polymer may be selected from quatemized alkylhydroxyethylcelluloses containing C8-C30 fatty chains.
The composition according to the present invention may be free of microplastic filler.
The (a) lipophilic organic UV filter may comprise a combination of at least one lipophilic organic UV-A filter and at least one lipophilic organic UV-B filter.
The amount of the (a) lipophilic organic UV filter(s) may be 1% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, and/or may be 50% by weight or less, preferably 40% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less, relative to the total weight of the composition.
The amount of the (b) powder(s) may be 1% by weight or more, preferably 3% by weight or more, more preferably 5% by weight or more, even more preferably 8% by weight or more, and in particular 10% by weight or more, and/or may be 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, even more preferably 18% by weight or less, and in particular 15% by weight or less, relative to the total weight of the composition.
The amount of the (c) cationic polymer(s) may be 0.001% by weight or more, preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, and/or may be 5% by weight or less, preferably 3% by weight or less, more preferably 1% by weight or less, and even more preferably 0.5% by weight or less, relative to the total weight of the composition.
The amount of the (d) oil(s) may be 3% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, and in particular 20% by weight or more, and/or may be 50% by weight or less, preferably 40% by weight or less, more preferably 35% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
The composition according to the present invention may further comprise at least one inorganic UV filter.
The inorganic UV filter may have an average particle size of less than 200 nm.
The amount of the inorganic UV filter may be 0.5% by weight or more, preferably 1% by weight or more, and more preferably 1.5% by weight or more, and may be 15% by weight or less, preferably 10% by weight or less, more preferably 7% by weight or less, and even more preferably 5% weight or less, relative to the total weight of the composition.
The present invention also relates to a cosmetic process for a keratin substrate, such as skin, comprising applying to the keratin substrate the composition according to the present invention.
BEST MODE FOR CARRYING OUT THE INVENTION
After diligent research, the inventors have surprisingly discovered that a W/O emulsion composition comprising a combination of at least one lipophilic organic UV filter, at least one powder other than microplastic filler, and at least one cationic polymer in the water phase can show an improved water resistant property, fresh sensation on application, and good stability, even if it is free of microplastic filler, and thus completed the present invention.
Thus, the present invention relates to a W/O emulsion composition, comprising:
(a) at least one lipophilic organic UV filter,
(b) at least one powder other than microplastic filler,
(c) at least one cationic polymer, and
(d) at least one oil, wherein the composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.
Hereinafter, the W/O emulsion composition and cosmetic process according to the present invention will be explained in a more detailed manner.
[Composition]
The composition according to the present invention includes (a) at least one lipophilic organic UV filter, and (b) at least one powder other than microplastic filler, (c) at least one cationic polymer, and (d) at least one oil. The ingredients in the composition will be described in a detailed manner below.
(Lipophilic Organic UV filter) The composition according to the present invention comprises (a) at least one lipophilic organic UV filter. Two or more lipophilic organic UV filters may be used in combination. Thus, a single type of lipophilic organic UV filter or a combination of different types of lipophilic organic UV filters may be used.
The term “UV” here comprises the UV-B region (260-320 nm in wavelength), the UV-A region (320-400 nm in wavelength), and the high energy visible light region (400-450 nm in wavelength). Therefore, a UV filter means any material which has filtering effects in the wavelength of UV rays, in particular the UV-A, UV-B, and high energy visible light regions.
The UV filter(s) used for the present invention may be active in the UV-A and/or UV-B region, preferably in each of the UV-A and UV-B regions alone or in combination. Therefore, the UV filter(s) used in the present invention include(s) a UV-A filter capable of absorbing UV radiation from 320 to 400 nm, a UV-B filter capable of absorbing UV radiation from 280 to 320 nm, and a UV-A and UV-B filter capable of absorbing UV radiation from 280 to 400 nm.
The term “lipophilic UV filter” here means UV filters which are soluble in oils at a concentration of at least 1% by weight relative to the total weight of the oils at room temperature (25°C) and atmosphere pressure (105 Pa).
The lipophilic organic UV filter may be solid or liquid. The terms “solid” and “liquid” mean solid and liquid, at room temperature (25 °C) and atmosphere pressure (105 Pa).
The lipophilic organic UV-A filters used in the present invention may include, but are not limited to, aminobenzophenone compounds, dibenzoylmethane compounds, anthranilic acid compounds, and 4,4-diarylbutadiene compounds.
As the aminobenzophenone compounds, mention may be made of n-hexyl 2-(4-diethlamino-2- hydroxybenzoyl)benzoate, the alternative name of which is diethylamino hydroxybenzoyl hexyl benzoate (DHHB), sold under the trade name “Uvinul A+” from BASF.
As the dibenzoylmethane compounds, mention may be made of 4-isopropyldibenzoylmethane, sold under the name of “Eusolex 8020” from Merck, l-(4-methoxy-l-benzofuran-5-yl)-3- phenylpropane-l,3-dione, sold under the name of “Pongamol” from Quest, l-(4-(tert- butyl)phenyl)-3-(2-hydroxyphenyl)propane-l,3-dione, and butyl methoxydibenzoylmethane, sold under the trade name “Parsol 1789” from Hoffmann -La Roche.
As the anthranilic acid compounds, mention may be made of menthyl anthranilate marketed under the name "NEO HELIPAN MA" by Symrise.
As the 4,4-diarylbutadiene compounds, mention may be made of 1,1 -dicarboxy (2,2'- dimethylpropyl)-4,4-diphenylbutadiene and diphenyl butadiene malonates and malononitriles.
The lipophilic organic UV-B filters used in the present invention may include, but are not limited to, triazine compounds, para-aminobenzoic acid compounds, salicylic compounds, cinnamate compounds, b,b-diphenylacrylate compounds, benzylidenecamphor compounds, phenylbenzimidazole compounds, imidazoline compounds, benzalmalonate compounds, and merocyanine compounds.
As the triazine compounds, mention may be made of ethylhexyl triazone, marketed under the name “UVINUL T-150” by BASF, diethylhexyl butamido triazone, marketed under the name “UVASORB HEB” by SIGMA 2V, 2,4,6-tris(dineopentyl 4,-aminobenzalmalonate)-s-triazine, 2,4,6-tris(diisobutyl 4’-aminobenzalmalonate)-s-triazine, 2,4-bis(dineopentyl 4’- aminobenzalmalonate)-6-(n-butyl 4,-aminobenzoate)-s-triazine, and 2,4-bis(n-butyl 4’- aminobenzoate)-6-(aminopropyltrisiloxane)-s-triazine.
As the para-aminobenzoic acid derivatives, mention may be made of para-aminobenzoates (PABA), for example, ethyl PABA (para-aminobenzoate), ethyl dihydroxypropyl PABA, and ethylhexyl dimethyl PABA, marketed under the name “ESCALOL 5972 from ISP.
As the salicylic compounds, mention may be made of homosalate, marketed under the name “Eusolex HMS” by Rona/EM industries, and ethylhexyl salicylate, marketed under the name “NEO HELIOPAN OS” by Symrise.
As the cinnamate compounds, mention may be made of ethylhexyl methoxycinnamate, marketed under the name “PARSOL CX” by DSM NUTRITIONAL PRODUCTS, isopropyl ethoxy cinnamate, isoamyl methoxy cinnamate, marketed under the name “NEO HELIOPAN E 1000” by Symrise, diisopropyl methylcinnamate, cinoxate, and glyceryl ethylhexanoate dimethoxycinnamate.
As the b,b-diphenylacrylate compounds, mention may be made of octocrylene, marketed under the name “UVINUL N539” by BASF, and etocrylene, marketed under the name “UVINUL N35” by BASF.
As the benzylidenecamphor compounds, mention may be made of 3-benzylidene camphor, marketed under the name “MEXORYL SD” from CHIMEX, methylbenzylidene camphor, marketed under the name “EUSOLEX 6300” by MERCK, polyacrylamidomethyl benzylidene Camphor, marketed under the name “MEXORYL SW” by CHIMEX, and terephthalylidene dicamphor sulfonic acid, marketed under the name “Mexoryl SX” by Chimex.
As the phenylbenzimidazole compounds, mention may be made of phenylbenzimidazole sulfonic acid, marketed under the name “Eusolex 232” by Merck, and disodium phenyl dibenzimidazole tetrasulfonate, marketed under the name “Neo Heliopan AP” by Haarmann and Reimer.
As the imidazoline compounds, mention may be made of ethylhexyl dimethoxybenzylidene dioxoimidazoline propionate.
As the benzalmalonate compounds, mention may be made of polyorganosiloxane containing a benzalmalonate moiety, for example, Polysilicone- 15, marketed under the name “Parsol SLX” by DSM NUTRITIONAL PRODUCTS, and di-neopentyl 4'-methoxybenzalmalonate.
The lipophilic organic UV filters of the present invention may comprise lipophilic organic UV-A and UV-B filters, which cover UV-A and UV-B regions. The following are non-limiting examples of the lipophilic organic UV-A and UV-B filters:
- Benzophenone compounds, such as benzophenone-1 marketed under the name “UVINUL 400” by BASF, benzophenone-2 marketed under the name “UVINUL 500” by BASF, benzophenone-3 or oxybenzone marketed under the name “UVINUL M40” by BASF, benzophenone-6 marketed under the name “Helisorb 11” by Norquay, benzophenone-8 marketed under the name “Spectra- Sorb UV-24” by American Cyanamid, benzophenone- 10, benzophenone-11, and benzophenone- 12; - benzotriazole compounds such as drometrizole trisiloxane marketed under the name “Silatrizole” by Rhodia Chimie, bumetrizole marketed under the name “TINOGUARTD AS” by CIBA- GEIGY ,and , phenylbenzotriazole derivatives: 2-(2H-benzotriazole-2-yl)-6-dodecyl-4- methylpheno, branched and linear;
- bis-resorcinyl triazine compounds, such as bis-ethylhexyloxyphenol methoxyphenyl triazine marketed under the name “TINOSORB S” by CIBA-GEIGY; and
- benzoxazole compounds, such as 2,4-bis[5-(l-dimethylpropyl) benzoxazol-2-yl(4- phenyl)imino]-6-(2-ethylhexyl)imino-l,3,5-triazine marketed under the name “Uvasorb K2A” by Sigma 3 V.
Preferably, the lipophilic organic UV filter may be selected from aminobenzophenone compounds, such as diethylamino hydroxybenzoyl hexyl benzoate (DHHB), dibenzoylmethane compounds, such as butyl methoxydibenzoylmethane, triazine compounds, such as ethylhexyl triazone, salicylic compounds, such as homosalate, b,b-diphenylacrylate compounds, such as octocrylene, and benzotriazole compounds, such as drometrizole trisiloxane, and mixtures thereof.
In one preferred embodiment of the present invention, the lipophilic organic UV filter of the present invention comprises a combination of at least one lipophilic organic UV-A filter and at least one lipophilic organic UV-B filter.
Therefore, in another preferred embodiment of the present invention, the lipophilic organic UV filter comprises at least one lipophilic organic UV-A filter selected from aminobenzophenone compounds and dibenzoylmethane compounds, and at least one lipophilic organic UV-B filter selected from triazine compounds, salicylic compounds, b,b-diphenylacrylate compounds, and benzotriazole compounds.
The amount of the lipophilic organic UV filter(s) in the composition according to the present invention may be 1% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, relative to the total weight of the composition. The amount of the lipophilic organic UV filter(s) in the composition may be 40% by weight or less, preferably 35% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less, relative to the total weight of the composition.
In one particular embodiment of the present invention, the amount of the lipophilic organic UV-A filter(s) in the composition is 0.5% by weight or more, preferably 1% by weight or more, and more preferably 2% by weight or more, and is 15% by weight or less, preferably 10% by weight or less, and more preferably 7% by weight or less, relative to the total weight of the composition.
In another particular embodiment of the present invention, the amount of the lipophilic organic UV-B filter(s) in the composition is 1% by weight or more, preferably 5% by weight or more, and more preferably 8% by weight or more, and is 30% by weight or less, preferably 20% by weight or less, and more preferably 15% by weight or less, relative to the total weight of the composition.
In yet another particular embodiment of the present invention, the amount of the lipophilic organic UV-A and UV-B filter(s) in the composition is 0.5% by weight or more, preferably 1% by weight or more, and more preferably 1.5% by weight or more, and is 10% by weight or less, preferably 7% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.
(Powder other than microplastic filler) The composition according to the present invention comprises (b) at least one powder other than microplastic filler. Two or more powders may be used in combination. Thus, a single type of powder or a combination of different types of powders may be used.
The term “powder” should be understood as meaning colorless or white, mineral or natural particles of any shape, which are insoluble in the medium of the composition, irrespective of the temperature at which the composition is manufactured.
The (b) powder is selected from powders other than microplastic fillers.
The term “microplastic filler” here means a synthetic polymer filler having an average particle size of 5 mm or less. The term “microplastic filler” here is also understood to mean polymeric solid particle insoluble in water which has size less than 5mm (all dimension) and stable throughout the life cycle.
The microplastic filler may include, but not limited to, acrylic polymer powders, silicone powders, wax powders, polyamide powders, urethane polymer powders, tetrafluoroethylene polymer powders, polyacrylonitrile powders, poly-β-alanine powders, polyethylene powders, polytetrafluoroethylene powders, lauroyllysine, tetrafluoroethylene polymer powders.
The (b) powder may be of any shape, platelet-shaped, spherical or oblong, irrespective of the crystallographic form (for example lamellar, cubic, hexagonal, orthorhombic, etc.).
The average particle size of the (b) powder is not limited, but in general is 50 pm or less, preferably 20 pm or less, and more preferably 15 pm or less. The average particle size of the (b) powder is 0.2 pm or more, preferably 0.5 pm or more, and more preferably 1 pm or more. The term “average particle size” used herein represents a number-average size mean diameter which is given by the statistical particle size distribution to half of the population, referred to as D50. For example, the number-average size mean diameter can be measured by a laser diffraction particle size distribution analyzer, such as Mastersizer 2000 by Malvern Corp.
The (b) powder can be an inorganic or organic powder, which may or may not be surface-coated.
As the inorganic powder, mention may be made of talc, mica, silica, silica silicate, magnesium aluminum silicate, kaolin, bentone, calcium carbonate, magnesium hydrogen carbonate, hydroxyapatite, boron nitride, fluorphlogopite, sericite, calcinated talc, calcinated mica, calcinated sericite, synthetic mica, perlite, lauroyl lysine, metal soap, bismuth oxychloride, barium sulfate, magnesium carbonate, and mixtures thereof, optionally hydrophilic- or hydrophobic-treated.
As the organic powder, mention may be made of natural polymer powders, such as polysaccharide powders and derivatives thereof, for example, starch, cellulose powder, and mixtures thereof.
It would be important to mention that the (b) powder of the present invention is different from a so-called “inorganic UY filter”, such as titanium oxide. The (b) powder does not have an active, substantive UV filtering effect, while it can contribute to form a homogeneous and fine film on keratinous substances, such as skin, by the composition according to the present invention. Therefore, the (b) powder of the present invention is not an inorganic UV filter, such as titanium oxide. Typically, inorganic UV filler is characterized by its fine particle size, and generally has less than 200 nm of average particle size. The (b) powder may or may not be surface-coated. The coating may be an inorganic substance and/or an organic substance. In one embodiment of the present invention, the (b) powder is not surface-coated.
The inorganic coating may be selected from metal oxides, such as silica, aluminum oxides, titanium oxides, zirconium oxides, cerium oxide, chromium oxide, and iron oxides, and metal hydroxides, such as aluminum hydroxide.
The organic coating may be selected from fatty acids or salts thereof (such as sodium, potassium, zinc, iron or aluminum salts), fatty alcohols, lecithin, amino acids, polysaccharides, proteins, alkanolamines, waxes such as beeswax, (meth)acrylic polymers, and (per)fluoro compounds.
In one embodiment of the present invention, the (b) powder does not comprise synthetic coating which may cause the environmental problems in the same manner as microplastic filler.
The amount of the (b) powder(s) in the composition according to the present invention may be 1% by weight or more, preferably 3% by weight or more, more preferably 5% by weight or more, even more preferably 8% by weight or more, and in particular 10% by weight or more, and may be 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, even more preferably 18% by weight or less, and in particular 15% by weight or less, relative to the total weight of the composition.
(Cationic Polymer)
The composition according to the present invention comprises (c) at least one cationic polymer. Two or more types of cationic polymer may be used in combination. Thus, a single type of cationic polymer or a combination of different types of cationic polymers may be used.
A cationic polymer has a positive charge density. The charge density of the cationic polymer may be from 0.01 meq/g to 20 meq/g, preferably from 0.05 tol5 meq/g, and more preferably from 0.1 to 10 meq/g.
The cationic polymer is hydrophilic or water soluble. Therefore, the cationic polymer is present in the water phase of the W/O emulsion composition according to the present invention.
It is preferable that the molecular weight of the cationic polymer be 500 or more, preferably 1000 or more, more preferably 2000 or more, and even more preferably 5000 or more.
Unless otherwise defined in the description, “molecular weight” means a number average molecular weight.
The cationic polymer may have at least one positively chargeable and/or positively charged moiety selected from the group consisting of a primary, secondary or tertiary amino group, a quaternary ammonium group, a guanidine group, a biguanide group, an imidazole group, an imino group, and a pyridyl group. The term (primary) “amino group” here means the -NH2 group.
The cationic polymer may be a homopolymer or a copolymer. The term “copolymer” is understood to mean both copolymers obtained from two kinds of monomers and those obtained from more than two kinds of monomers, such as terpolymers obtained from three kinds of monomers.
The cationic polymer may be selected from natural and synthetic cationic polymers. Nonlimiting examples of the cationic polymers are as follows.
(1) Homopolymers and copolymers derived from acrylic or methacrylic esters and amides and comprising at least one unit chosen from units of the following formulas:
Figure imgf000010_0001
wherein:
R1 and R2, which may be identical or different, are chosen from hydrogen and alkyl groups comprising from 1 to 6 carbon atoms, for instance, methyl and ethyl groups;
R3, which may be identical or different, is chosen from hydrogen and CH3; the symbols A, which may be identical or different, are chosen from linear or branched alkyl groups comprising from 1 to 6 carbon atoms, for example, from 2 to 3 carbon atoms and hydroxyalkyl groups comprising from 1 to 4 carbon atoms;
R4, R5, and R6, which may be identical or different, are chosen from alkyl groups comprising from 1 to 18 carbon atoms and benzyl groups, and in at least one embodiment, alkyl groups comprising from 1 to 6 carbon atoms; and
X is an anion derived from an inorganic or organic acid, such as methosulphate anions and halides, for instance chloride and bromide.
The copolymers of family (1) may also comprise at least one unit derived from comonomers which may be chosen from acrylamides, methacrylamides, diacetone acrylamides, acrylamides and methacrylamides substituted on the nitrogen atom with (C1-C4) lower alkyl groups, groups derived from acrylic or methacrylic acids and esters thereof, vinyllactams such as vinylpyrrolidone and vinylcaprolactam, and vinyl esters.
Examples of copolymers of family (1) include, but are not limited to: copolymers of acrylamide and of dimethylaminoethyl methacrylate quatemized with dimethyl sulphate or with a dimethyl halide, copolymers of acrylamide and of methacryloyloxyethyltrimethylammonium chloride described, for example, in European Patent Application No. 0080976, copolymers of acrylamide and of methacryloyloxyethyltrimethylammonium methosulphate, quatemized or nonquatemized vinylpyrrolidone/dialkylaminoalkyl acrylate or methacrylate copolymers, described, for example, in French Patent Nos. 2077 143 and 2393 573, dimethylaminoethyl methacrylate/vinylcaprolactam/vinylpyrrolidone terpolymers, vinylpyrrolidone/methaciylamidopropyldimethylamine copolymers, quatemized vinylpyrrolidone/dimethylaminopropylmethacrylamide copolymers, and crosslinked methacryloyloxy(C1-C4)alkyltri(C1-C4)alkyl ammonium salt polymers such as the polymers obtained by homopolymerization of dimethylaminoethyl methacrylate quatemized with methyl chloride, or by copolymerization of acrylamide with dimethylaminoethyl methacrylate quatemized with methyl chloride, the homopolymerization or copolymerization being followed by crosslinking with a compound containing an olefmic unsaturation, for example, methylenebisacrylamide.
Preferably, copolymers of family (1) have a unit derived from vinylpyrrolidone. More preferably, copolymers of family (1) have at least one pendent ring structure derived from vinylpyrrolidone. On the other hand, it is preferable that the copolymers of family ( 1 ) comprise no ring structure in the backbone of the polymer.
The copolymers of family (1) having vinylpyrrolidone units can be selected from:
(i) the copolymers comprising vinylpyrrolidone units and dimethylaminoethyl methacrylate units, for example: vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer (20/80 by weight) sold under the trade name Copolymer 845 by the company I.S.P., vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers quatemized with diethyl sulphate; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate copolymer quatemized with diethyl sulphate, sold under the trade names Gafquat 734, 755, 755S and 755L by the company I.S.P., vinylpyrrolidone/dimethylaminoethyl methacrylate/hydrophilic polyurethane copolymers; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate/hydrophilic polyurethane copolymer, sold under the trade name Pecogel GC-310 by the company U.C.I.B., or under the trade names Aquamere C 1031 and C 1511 by the company Blagden Chemicals,
- vinylpyrrolidone/dimethylaminoethyl methacrylate/C8-C16 olefin copolymers, quatemized or non-quaternized; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate/C8-C16 olefin copolymer sold under the trade names Ganex ACP1050 to 1057, 1062-1069 and 1079- 1086 by the company I.S.P., and
- vinylpyrrolidone/dimethylaminoethyl methacrylate/vinylcaprolactam copolymers; for example, vinylpyrrolidone/dimethylaminoethyl methacrylate/vinylcaprolactam copolymer sold under the trade name Gaffix VC713 by the company I. S .P;
(ii) the copolymers comprising vinylpyrrolidone units and methacrylamidopropyltrimethylammonium (MAPTAC) units, for example: vinylpyrrolidone/methacrylamidopropyltrimethylammonium copolymers; for example, vinylpyrrolidone/MAPTAC copolymer sold under the trade names Gafquat ACP 1011 and Gafquat HS100 by the company I.S.P., and - vinylpyrrolidone/methacrylamidopropyltrimethylammonium/vinylcaprolactam terpolymers; for example, vinylpyrrolidone/MAPTAC/vinylcaprolactam terpolymer sold under the trade names Polymer ACP 1059, 1060 and 1156 by the company I.S.P.; and
(iii) the copolymers comprising vinylpyrrolidone units and methylvinylimidazolium units, for example:
- vinylpyrrolidone/methylvinylimidazolium chloride copolymers; for example, vinylpyrrolidone/methylvinylimidazolium chloride copolymer sold under the trade names Luviquat FC370, FC550, FC905 and HM552 by the company BASF,
- vinylpyrrolidone/methylvinylimidazolium chloride/vinylimidazole copolymers; for example, vinylpyrrolidone/methylvinylimidazolium chloride/vinylimidazole copolymer sold under the trade name Luviquat 8155 by the company BASF, and
- vinylpyrrolidone/methylvinylimidazolium methosulphate copolymers; for example, vinylpyrrolidone/methylvinylimidazolium methosulphate copolymer sold under the trade name Luviquat MS370 by the company BASF.
It is preferable that the copolymers of family (1) be chosen from the copolymer comprising vinylpyrrolidone units and dimethylaminoethyl methacrylate units, more preferably chosen from vinylpyrrolidone/dimethylaminoethyl methacrylate copolymers quatemized with diethyl sulphate, and even more preferably Polyquatemium-11.
(2) Cationic cellulose derivatives such as cellulose ether derivatives comprising quaternary ammonium groups described, for example, in French Patent No. 1 492 597, such as the polymers sold under the names "JR" (JR 400, JR 125, JR 30M) or "LR" (LR 400, LR 30M) by the company Union Carbide Corporation. These polymers are also defined in the CTFA dictionary as quaternary ammoniums of hydroxyethylcellulose that have reacted with an epoxide substituted with a trimethylammonium group.
It is preferable that the cationic cellulose derivatives be quatemized hydroxyethyl celluloses modified with at least one quaternary ammonium group comprising at least one fatty chain, such as alkyl, arylalkyl or alkylaryl groups comprising at least 8 carbon atoms, or mixtures thereof.
The alkyl radicals borne by the quaternary ammonium group may preferably contain from 8 to 30 carbon atoms, especially from 10 to 30 carbon atoms. The aryl radicals preferably denote phenyl, benzyl, naphthyl or anthryl groups.
More preferably, the cationic cellulose derivatives may comprise at least one quaternary ammonium group including at least one C8-C30 hydrocarbon group.
Examples of quatemized alkylhydroxyethylcelluloses containing C8-C30 fatty chains that may be mentioned include the products Quatrisoft LM 200, Quatrisoft LM-X 529-18-A, Quatrisoft LM-X 529-18B (C12 alkyl) and Quatrisoft LM-X 529-8 (C18 alkyl) or Softcat Polymer SL100, Softcat SX-1300X, Softcat SX-1300H, Softcat SL-5, Softcat SL-30, Softcat SL-60 , Softcat SK-MH, Softcat SX-400X, Softcat SX-400H, SoftCat SK-L, Softcat SK-M, and Softcat SK-H, sold by the company Amerchol and the products Crodacel QM, Crodacel, QL (Cl 2 alkyl) and Crodacel QS (Cl 8 alkyl) sold by the company Croda.
It is preferable that the cationic polymer be selected from the group consisting of Polyquatemium- 24, Polyquatemium-67 and mixtures thereof. Polyquatemium-67 is most preferable.
From another viewpoint, the cationic cellulose derivatives could also be chosen among cationic cellulose ether(s), comprising from 4000 to 10000 anhydroglucose units, said anhydroglucose units being substituted with at least:
(i) one substituent of formula
[R4R5R6R9N+](X2-) in which
R4 and R5 represent, independently of one another, a methyl or ethyl group,
R6 represents a linear or branched C8-C24 alkyl group or an aralkyl group in which the linear or branched alkyl part is C8-C24,
R9 represents a divalent group which allows the attachment to the anhydroglucose group and which is chosen from -(B)q-CH2-CHOH-CH2- and -CH2CH2-, q denoting 0 or 1 ,
B denoting the divalent group -(CH2CH20)n'-, ri being an integer ranging from 1 to 100,
X2 ' represents an anion; and
(ii) one substituent of formula
[R,R2R3R8N+](X1-) in which:
R1, R2 and R3 represent, independently of one another, a methyl or ethyl group,
R8 represents a divalent group which allows the attachment to the anhydroglucose group and which is chosen from -(A)p-CH2-CHOH-CH2- and -CH2CH2-, p denoting 0 or 1 ,
A denoting a divalent group -(CH2CH2O)n-, n being an integer ranging from 1 to 100, and Xf represents an anion.
Preferably, the substituent (i) of formula [R4R5R6R9N+](X2-) is present at an average of from 0.0003 to 0.08 mol, per mole of anhydroglucose units.
The cationic cellulose ethers that can be used in the compositions according to the present invention are preferably hydroxyethyl celluloses or hydroxypropyl celluloses. The cationic cellulose ethers that can be used in the compositions according to the present invention preferably comprise more than 4500, advantageously more than 5000, and more preferably more than 6000 anhydroglucose units.
Preferably, the cationic cellulose ethers that can be used in the compositions according to the present invention comprise up to 9000, and more preferably up to 8000 anhydroglucose units.
These cationic cellulose ethers and the process for the preparation thereof are described in application WO 2005/000903.
According to a preferred variant, the cationic cellulose ethers that can be used in the compositions according to the present invention are formed from at least one unit (IV) and at least one of the following units (I), (II) and (III):
Figure imgf000014_0001
with the proviso that: the total number of units (I)+(II)+(III)+(IV) is between 4000 and 10000; the [(III)+(IV)]/[(I)+(II)+(III)+(IV)] ratio ranges from 0.0003 to 0.8; the [(II)+(IV)]/[(I)+(II)+(III)+(IV)] ratio ranges from 0.02 to 0.9; the integers n and n', independently of one another, range from 0 to 5;
R1, R2, R3, R4 and R5 represent, independently of one another, a methyl or ethyl group;
R6 represents a linear or branched C8-C24, preferably C10-C24, more preferably C12-C24 and better still C12-C15, an lkyl group or an aralkyl group in which the linear or branched alkyl part is C8-C24;X1- and X2- represent anions preferably chosen, independently of one another, from phosphate, nitrate, sulphate and halide (Cl-, Br-, F-, G)- ions.
According to a particular variant, the cationic cellulose ethers that can be used in the compositions according to the present invention are formed from at least one unit (IV) and at least one of the units (I), (II) or (III) above, in which R6 is a linear dodecyl group.
Among the cationic cellulose ethers that can be used in the compositions of the present invention, mention may be made of the polymers of Softcat SL-5, SL-30, SL-60 and SL-100 type (INCI: Polyquatemium-67) sold by the company Amerchol. The cationic cellulose ethers that are particularly preferred are the polymers of SL-60 and SL-100 type.
(3) Cationic cellulose derivatives such as cellulose copolymers and cellulose derivatives grafted with a water-soluble monomer of quaternary ammonium, and described, for example, in U.S. Pat. No. 4,131,576, such as hydroxyalkylcelluloses, for instance, hydroxymethyl-, hydroxyethyl-, and hydroxypropylcelluloses grafted, for example, with a salt chosen from methacryloylethyltrimethylammonium, methacrylamidopropyltrimethylammonium, and dimethyldiallylammonium salts.
Commercial products corresponding to these polymers include, for example, the products sold under the name "Celquat® L 200" and "Celquat® H 100" by the company National Starch.
(4) Non-cellulose-based cationic polysaccharides described in U.S. Pat. Nos. 3,589,578 and 4,031,307, such as guar gums comprising cationic trialkylammonium groups, cationic hyaluronic acid, and dextran hydroxypropyl trimonium chloride. Guar gums modified with a salt, for example, the chloride, of 2,3-epoxypropyltrimethylammonium (guar hydroxypropyltrimonium chloride) may also be used.
Such products are sold, for instance, under the trade names JAGUAR® Cl 3 S, JAGUAR® Cl 5, JAGUAR® Cl 7, and JAGUAR® Cl 62 by the company MEYHALL.
(5) Polymers comprising piperazinyl units and divalent alkylene or hydroxyalkylene groups comprising straight or branched chains, optionally interrupted with at least one entity chosen from oxygen, sulphur, nitrogen, aromatic rings, and heterocyclic rings, and also the oxidation and/or quaternization products of these polymers. Such polymers are described, for example, in French Patent Nos. 2 162025 and 2280361.
(6) Water-soluble polyamino amides prepared, for example, by polycondensation of an acidic compound with a polyamine; these polyamino amides possibly being crosslinked with an entity chosen from epihalohydrins; diepoxides; dianhydrides; unsaturated dianhydrides; bisunsaturated derivatives; bishalohydrins; bisazetidiniums; bishaloacyidiamines; bisalkyl halides; oligomers resulting from the reaction of a difunctional compound which is reactive with an entity chosen from bishalohydrins, bisazetidiniums, bishaloacyldiamines, bisalkyl halides, epihalohydrins, diepoxides, and bisunsaturated derivatives; the crosslinking agent being used in an amount ranging from 0.025 to 0.35 mol per amine group of the polyamino amide; these polyamino amides optionally being alkylated or, if they comprise at least one tertiary amine function, they may be quatemized. Such polymers are described, for example, in French Patent Nos. 2252 840 and 2 368 508.
(7) Polyamino amide derivatives resulting from the condensation of polyalkylene polyamines with polycarboxylic acids, followed by alkylation with difunctional agents, for example, adipic acid/dialkylaminohydroxyalkyldialkylenetriamine polymers in which the alkyl group comprises from 1 to 4 carbon atoms, such as methyl, ethyl, and propyl groups, and the alkylene group comprises from 1 to 4 carbon atoms, such as an ethylene group. Such polymers are described, for instance, in French Patent No. 1 583 363. In at least one embodiment, these derivatives may be chosen from adipic acid/dimethylaminohydroxypropyldiethylenetriamine polymers.
(8) Polymers obtained by reaction of a polyalkylene polyamine comprising two primary amine groups and at least one secondary amine group, with a dicarboxylic acid chosen from diglycolic acid and saturated aliphatic dicarboxylic acids comprising from 3 to 8 carbon atoms. The molar ratio of the polyalkylene polyamine to the dicarboxylic acid may range from 0.8: 1 to 1.4: 1 ; the polyamino amide resulting therefrom being reacted with epichlorohydrin in a molar ratio of epichlorohydrin relative to the secondary amine group of the polyamino amide ranging from 0.5:1 to 1.8:1. Such polymers are described, for example, in U.S. Pat. Nos. 3,227,615 and 2,961 ,347.
(9) Cyclopolymers of alkyldiallylamine and cyclopolymers of dialkyldiallyl-ammonium, such as homopolymers and copolymers comprising, as the main constituent of the chain, at least one unit chosen from units of formulas (la) and (lb):
Figure imgf000016_0001
wherein: k and t, which may be identical or different, are equal to 0 or 1 , the sum k+t being equal to 1 ; R12 is chosen from hydrogen and methyl groups; R10 and Rn, which may be identical or different, are chosen from alkyl groups comprising from 1 to 6 carbon atoms, hydroxyalkyl groups in which the alkyl group comprises, for example, from 1 to 5 carbon atoms, and lower (C1-C4)amidoalkyl groups, or R10 and R11 may form, together with the nitrogen atom to which they are attached, heterocyclic groups such as piperidinyl and morpholinyl; and
Y' is an anion such as bromide, chloride, acetate, borate, citrate, tartrate, bisulphate, bisulphite, sulphate, and phosphate. These polymers are described, for example, in French Patent No. 2080 759 and in its Certificate of Addition 2 190406.
In one embodiment, R10 and R11, which may be identical or different, are chosen from alkyl groups comprising from 1 to 4 carbon atoms.
Examples of such polymers include, but are not limited to, (co)polydiallyldialkyl ammonium chloride such as the dimethyidiallylammonium chloride homopolymer sold under the name "MERQUAT® 100" by the company CALGON (and its homologues of low weight-average molecular mass) and the copolymers of diallyldimethylammonium chloride and of acrylamide sold under the name "MERQUAT® 550".
Quaternary diammonium polymers comprising at least one repeating unit of formula (II):
Figure imgf000017_0001
wherein: R13, R14, R15, and R16, which may be identical or different, are chosen from aliphatic, alicyclic, and arylaliphatic groups comprising from 1 to 20 carbon atoms and lower hydroxyalkyl aliphatic groups, or alternatively Rn, Rn, Rn, and Rn may form, together or separately, with the nitrogen atoms to which they are attached, heterocycles optionally comprising a second heteroatom other than nitrogen, or alternatively R13, R14, R15, and R16, which may be identical or different, are chosen from linear or branched C1-C6 alkyl groups substituted with at least one group chosen from nitrile groups, ester groups, acyl groups, amide groups, -CO-O- R17-E groups, and -CO-NH- R17-E groups, wherein Rn is an alkylene group and E is a quaternary ammonium group;
A1 and B1, which may be identical or different, are chosen from polymethylene groups comprising from 2 to 20 carbon atoms, which may be linear or branched, saturated or unsaturated, and which may comprise, linked or intercalated in the main chain, at least one entity chosen from aromatic rings, oxygen, sulphur, sulphoxide groups, sulphone groups, disulphide groups, amino groups, alkylamino groups, hydroxyl groups, quaternary ammonium groups, ureido groups, amide groups, and ester groups, and
X- is an anion derived from an inorganic or organic acid;
A1, R13, and R15 may form, together with the two nitrogen atoms to which they are attached, a piperazine ring; if A 1 is chosen from linear or branched, saturated or unsaturated alkylene or hydroxyalkylene groups, Bi may be chosen from:
-(CH2)n-CO-E'-OC-(CH2)n- wherein E' is chosen from: a) glycol residues of formula -O-Z-O-, wherein Z is chosen from linear or branched hydrocarbon- based groups and groups of the following formulas: -(CH2-CH2-O)X-CH2-CH2-
-[CH2-CH(CH3)-O]y-CH2-CH(CH3)- wherein x and y, which may be identical or different, are chosen from integers ranging from 1 to 4, which represent a defined and unique degree of polymerization, and numbers ranging from 1 to 4, which represent an average degree of polymerization; b) bis-secondary diamine residue such as piperazine derivatives; c) bis-primary diamine residues of formula -NH-Y-NH-, wherein Y is chosen from linear or branched hydrocarbon-based groups and the divalent group -CH2-CH2-S-S-CH2-CH2-; and d) ureylene groups of formula -NH-CO-NH-.
In at least one embodiment, X- is an anion such as chloride or bromide.
Polymers of this type are described, for example, in French Patent Nos. 2320330; 2270 846; 2 316271; 2 336434; and 2413 907 and U.S. Pat. Nos. 2,273,780; 2,375,853; 2,388,614; 2,454,547; 3,206,462; 2,261,002; 2,271,378; 3,874,870; 4,001,432; 3,929,990; 3,966,904; 4,005,193; 4,025,617; 4,025,627; 4,025,653; 4,026,945; and 4,027,020.
Non-limiting examples of such polymers include those comprising at least one repeating unit of formula (III):
Figure imgf000018_0001
wherein R13, R14, R15, and R16, which may be identical or different, are chosen from alkyl and hydroxyalkyl groups comprising from 1 to 4 carbon atoms, n and p, which may be identical or different, are integers ranging from 2 to 20, and X' is an anion derived from an inorganic or organic acid.
(11) Polyquatemary ammonium polymers comprising units of formula (IV) :
Figure imgf000018_0002
wherein: R18, R19, R20, and R21, which may be identical or different, are chosen from hydrogen, methyl groups, ethyl groups, propyl groups, b-hydroxyethyl groups, b-hydroxypropyl groups, - CH2CH2(OCH2CH2)pOH groups, wherein p is chosen from integers ranging from 0 to 6, with the proviso that R18, R19, R20, and R21 are not simultaneously hydrogen, r and s, which may be identical or different, are chosen from integers ranging from 1 to 6, q is chosen from integers ranging from 0 to 34,
X- is an anion such as a halide, and
A is chosen from radicals of dihalides and -CH2-CH2-O-CH2-CH2-. Such compounds are described, for instance, in European Patent Application No. 0 122324.
(12) Quaternary polymers of vinylpyrrolidone and of vinylimidazole.
Other examples of suitable cationic polymers include, but are not limited to, cationic proteins and cationic protein hydrolysates, polyalkyleneimines, such as polyethyleneimines, polymers comprising units chosen from vinylpyridine and vinylpyridinium units, condensates of polyamines and of epichlorohydrin, quaternary polyureylenes, and chitin derivatives.
According to one embodiment of the present invention, the at least one cationic polymer is chosen from cellulose ether derivatives comprising quaternary ammonium groups, such as the products sold under the name "JR 400" by the company UNION CARBIDE CORPORATION, cationic cyclopolymers, for instance, the homo-polymers and copolymers of dimethyldiallylammonium chloride sold under the names MERQUAT® 100, MERQUAT® 550, and MERQUAT® S by the company CALGON, guar gums modified with a 2,3-epoxypropyltrimethylammonium salt, and quaternary polymers of vinylpyrrolidone and of vinylimidazole.
(13) Polyamines
As the cationic polymer, it is also possible to use (co)polyamines, which may be homopolymers or copolymers, with a plurality of amino groups. The amino group may be a primary, secondary, tertiary or quaternary amino group. The amino group may be present in a polymer backbone or a pendent group, if present, of the (co)polyamines.
As examples of the (co)polyamines, mention may be made of chitosan, (co)polyallylamines, (co)polyvinylamines, (co)polyanilines, (co)polyvinylimidazoles,
(co)polydimethylaminoethylenemethacrylates, (co)polyvinylpyridines such as (co)poly-l-methyl- 2-vinylpyridines, (co)polyimines such as (co)polyethyleneimines, (co)polypyridines such as (co)poly(quatemary pyridines), (co)polybiguanides such as (co)polyaminopropyl biguanides, (co)polylysines, (co)polyomithines, (co)polyarginines, (co)polyhistidines, aminodextrans, aminocelluloses, amino(co)polyvinylacetals, and salts thereof.
As the (co)polyamines, it is preferable to use (co)polylysines. Polylysine is well known. Polylysine can be a natural homopolymer of L-lysine that can be produced by bacterial fermentation. For example, polylysine can be e-Poly-L- lysine, typically used as a natural preservative in food products. Polylysine is a polyelectrolyte which is soluble in polar solvents such as water. Polylysine is commercially available in various forms, such as poly D-lysine and poly L-lysine. Polylysine can be in salt and/or solution form.
(14) Cationic Polyaminoacids
As the cationic polymer, it may be possible use cationic polyaminoacids, which may be cationic homopolymers or copolymers, with a plurality of amino groups and carboxyl groups. The amino group may be a primary, secondary, tertiary or quaternary amino group. The amino group may be present in a polymer backbone or a pendent group, if present, of the cationic polyaminoacids. The carboxyl group may be present in a pendent group, if present, of the cationic polyaminoacids.
As examples of the cationic polyaminoacids, mention may be made of cationized collagen, cationized gelatin, steardimonium hydroxypropyl hydrolyzed wheat protein, cocodimonium hydroxypropyl hydrolyzed wheat protein, hydroxypropyltrimonium hydrolyzed conchiolin protein, steardimonium hydroxypropyl hydrolyzed soy protein, hydroxypropyltrimonium hydrolyzed soy protein, cocodimonium hydroxypropyl hydrolyzed soy protein, and the like.
It may be preferable that the cationic polymer be selected from the group consisting of cyclopolymers of alkyldiallylamine and cyclopolymers of dialkyldiallylammonium such as (co)polydiallyldialkyl ammonium chloride, (co)polyamines such as (co)polylysines, cationic (co)polyaminoacids such as cationized collagen, and salts thereof.
It is preferable that the cationic polymer be a polyquatemium polymer or a polymeric quaternary ammonium salt.
Polymeric quaternary ammonium salts are cationic polymers comprising at least one quatemized nitrogen atom. Mention may in particular be made, as polymeric quaternary ammonium salts, of the Polyquatemium products (CTFA name), which contribute mainly to the quality of the foam and the feeling of the skin after use, in particular the feeling of the skin after use. These polymers can preferably be chosen from the following polymers:
Polyquatemium-5, such as the product Merquat 5 sold by Nalco;
Polyquatemium-6, such as the product Salcare SC 30 sold by BASF and the product Merquat 100 sold by Nalco;
Polyquatemium-7, such as the products Merquat S, Merquat 2200, Merquat 7SPR, and Merquat 550 sold by Nalco and the product Salcare SC 10 sold by BASF;
Polyquatemium- 10, such as the product Polymer JR400 sold by Amerchol;
Polyquatemium- 11, such as the products Gafquat 755, Gafquat 755N and Gafquat 734 sold by ISP;
Polyquatemium- 15, such as the product Rohagit KF 720 F sold by Rohm;
Polyquatemium- 16, such as the products Luviquat FC905, Luviquat FC370, Luviquat HM552 and Luviquat FC550 sold by BASF;
Polyquatemium-28, such as the product Styleze CC10 sold by ISP;
Polyquatemium-44, such as the product Luviquat Care sold by BASF;
Polyquatemium-46, such as the product Luviquat Hold sold by BASF;
Polyquatemium-47, such as the product Merquat 2001 sold by Nalco; and Polyquatemium-67, such as the product Softcat sold by Amerchol.
The amount of the cationic polymer(s) in the composition according to the present invention may be 0.001% by weight or more, preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, and may be 5% by weight or less, preferably 3% by weight or less, more preferably 1 % by weight or less, and even more preferably 0.5% by weight or less, relative to the total weight of the composition.
(Oil)
The composition according to the present invention comprises (d) at least one oil. Two or more oils may be used in combination. Thus, a single type of oil or a combination of different types of oils may be used.
Here, “oil” means a fatty compound or substance which is in the form of a liquid or a paste (nonsolid) at room temperature (25°C) under atmospheric pressure (760 mmHg). As the oils, those generally used in cosmetics can be used alone or in combination thereof. These oils may be volatile or non-volatile. The oil forms an oil phase of the W/O emulsion composition according to the present invention.
The oil may be a non-polar oil such as a hydrocarbon oil, a silicone oil, or the like; a polar oil such as a plant or animal oil and an ester oil or an ether oil; or a mixture thereof.
The oil may be selected from the group consisting of oils of plant or animal origin, synthetic oils, silicone oils, hydrocarbon oils, fatty alcohols and fatty acids.
As examples of plant oils, mention may be made of, for example, linseed oil, camellia oil, macadamia nut oil, com oil, olive oil, avocado oil, sasanqua oil, castor oil, safflower oil, jojoba oil, sunflower oil, almond oil, rapeseed oil, sesame oil, soybean oil, peanut oil, and mixtures thereof. As examples of animal oils, mention may be made of, for example, squalene and squalane. As examples of synthetic oils, mention may be made of alkane oils such as isododecane and isohexadecane, ester oils, ether oils, and artificial triglycerides.
The ester oils are preferably liquid esters of saturated or unsaturated, linear or branched C1-C26 aliphatic monoacids or polyacids and of saturated or unsaturated, linear or branched C1-C26 aliphatic monoalcohols or polyalcohols, the total number of carbon atoms of the esters being greater than or equal to 10.
Preferably, for the esters of monoalcohols, at least one from among the alcohol and the acid from which the esters of the present invention are derived is branched. Among the monoesters of monoacids and of monoalcohols, mention may be made of ethyl palmitate, ethyl hexyl palmitate, isopropyl palmitate, dicaprylyl carbonate, alkyl myristates such as isopropyl myristate or ethyl myristate, isocetyl stearate, 2-ethylhexyl isononanoate, isononyl isononanoate, isodecyl neopentanoate, and isostearyl neopentanoate.
Mention may especially be made of: diethyl sebacate; isopropyl lauroyl sarcosinate; diisopropyl sebacate; bis(2-ethylhexyl) sebacate; diisopropyl adipate; di-n-propyl adipate; dioctyl adipate; bis(2-ethylhexyl) adipate; diisostearyl adipate; bis(2-ethylhexyl) maleate; triisopropyl citrate; triisocetyl citrate; triisostearyl citrate; glyceryl trilactate; glyceryl trioctanoate; trioctyldodecyl citrate; trioleyl citrate; neopentyl glycol diheptanoate; and diethylene glycol diisononanoate.
As examples of ether oils, mention may be made of, for example, ether oils with a short hydrocarbon chain or chains, such as dicaprylyl ether.
As examples of artificial triglycerides, mention may be made of, for example, capryl caprylyl glycerides, glyceryl trimyristate, glyceryl tripalmitate, glyceryl trilinolenate, glyceryl trilaurate, glyceryl tricaprate, glyceryl tricaprylate, glyceryl tri(caprate/caprylate), and glyceryl tri(caprate/caprylate/linolenate).
As examples of silicone oils, mention may be made of, for example, linear organopolysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, methylhydrogenpolysiloxane, and the like; cyclic organopolysiloxanes such as cyclohexasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, and the like; and mixtures thereof. Preferably, the silicone oil is chosen from liquid polydialkylsiloxanes, especially liquid polydimethylsiloxanes (PDMS, dimethicone) and liquid polyorganosiloxanes comprising at least one aryl group. These silicone oils may also be organomodified. The organomodified silicones that can be used in accordance with the present invention are silicone oils as defined above and comprise in their structure one or more organofunctional groups attached via a hydrocarbon-based group.
Hydrocarbon oils may be chosen from: linear or branched, optionally cyclic, C6-C16 lower alkanes. Examples that may be mentioned include hexane, undecane, dodecane, tridecane, and isoparaffins, for instance isohexadecane, isododecane, and isodecane; linear or branched hydrocarbons containing more than 16 carbon atoms, such as liquid paraffins, liquid petroleum jelly, polydecenes and hydrogenated polyisobutenes such as Parleam®, and squalene; mixtures of alkanes, for example, C9- 12 Alkane, C 10- 13 Alkane, C 13 - 14 Alkane, C 13 - 15 Alkane, C14-17 Alkane, C14-19 Alkane, C15-19 Alkane, C15-23 Alkane, C18-21Alkane, C8-9 Alkane/Cycloalkane, C9-10 Alkane/Cycloalkane, C9-11 Alkane/Cycloalkane, C9-16
Alkane/Cycloalkane, Cl 0-12 Alkane/Cycloalkane, Cl 1-14 Alkane/Cycloalkane, Cl 1-15
Alkane/Cycloalkane, and C12-13 Alkane/Cycloalkane.
The term “fatty” in the fatty alcohol means the inclusion of a relatively large number of carbon atoms. Thus, alcohols which have 4 or more, preferably 6 or more, and more preferably 12 or more carbon atoms are encompassed within the scope of fatty alcohols. The fatty alcohol may be saturated or unsaturated. The fatty alcohol may be linear or branched.
The fatty alcohol may have the structure R-OH wherein R is chosen from saturated and unsaturated, linear and branched radicals containing from 4 to 40 carbon atoms, preferably from 6 to 30 carbon atoms, and more preferably from 12 to 20 carbon atoms. In at least one embodiment, R may be chosen from C12-C20 alkyl and C12-C20 alkenyl groups. R may or may not be substituted with at least one hydroxyl group. As examples of the fatty alcohol, mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, oleyl alcohol, linoleyl alcohol, palmitoleyl alcohol, arachidonyl alcohol, emcyl alcohol, and mixtures thereof. It is preferable that the fatty alcohol be a saturated fatty alcohol. Thus, the fatty alcohol may be selected from straight or branched, saturated or unsaturated C6-C30 alcohols, preferably straight or branched, saturated C6-C30 alcohols, and more preferably straight or branched, saturated C12-C20 alcohols. As examples of saturated fatty alcohols, mention may be made of lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, undecylenyl alcohol, myristyl alcohol, octyldodecanol, hexyldecanol, and mixtures thereof. In one embodiment, cetyl alcohol, stearyl alcohol, octyldodecanol, hexyldecanol, or a mixture thereof (e.g., cetearyl alcohol) as well as behenyl alcohol, can be used as a saturated fatty alcohol.
The fatty acids that may be used in the composition of the present disclosure may be saturated or unsaturated and comprise from 6 to 30 carbon atoms such as from 9 to 30 carbon atoms. As nonlimiting examples, they may be chosen from myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, and isostearic acid.
The amount of the oil(s) in the composition according to the present invention may be 3% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, and in particular 20% by weight or more, and may be 50% by weight or less, preferably 40% by weight or less, more preferably 35% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
(Other ingredients) • Cosmetically Acceptable Hydrophilic Organic Solvent
The composition according to the present invention may comprise at least one cosmetically acceptable hydrophilic organic solvent. The cosmetically acceptable hydrophilic organic solvent(s) may include, for example, substantially linear or branched lower mono-alcohols having from 1 to 8 carbon atoms, such as ethanol, propanol, butanol, isopropanol, and isobutanol; aromatic alcohols, such as benzyl alcohol and phenylethyl alcohol; polyols or polyol ethers, such as propylene glycol, dipropylene glycol, isoprene glycol, butylene glycol, pentylene glycol, glycerine, propanediol, sorbitol, ethylene glycol monomethyl, monoethyl and monobutyl ethers, propylene glycol ethers, such as propylene glycol monomethylether, diethylene glycol alkyl ethers, such as diethylene glycol monoethylether or monobutylether; polyethylene glycols, such as PEG-4, PEG- 6, and PEG-8, and their derivatives, and a combination thereof.
The amount of the cosmetically acceptable hydrophilic organic solvent(s) in the composition according to the present invention may range from 1 to 30% by weight, preferably from 2 to 25% by weight, and more preferably from 3 to 20% by weight, relative to the total weight of the composition.
• Surfactant
The composition according to the present invention may comprise at least one surfactant chosen from amphoteric, anionic, cationic, or nonionic surfactants, used alone or as a mixture. Preferably, the composition comprises at least one nonionic surfactant.
Examples of nonionic surfactants usable in the compositions of the invention may include polyethoxylated fatty alcohols or polyglycerolated fatty alcohols, such as the adducts of ethylene oxide with lauryl alcohol, especially those containing from 9 to 50 oxyethylene units (Laureth-9 to Laureth-50 as the INCI names), in particular Laureth-9; esters of polyols and of a fatty acid possessing a saturated or unsaturated chain comprising, for example, from 8 to 24 carbon atoms, and their oxyalkylenated derivatives, that is to say comprising oxyethylene and/or oxypropylene units, such as esters of glycerol and of a C8-C24 fatty acid, and their oxyalkylenated derivatives, in particular polyoxyethylenated glyceryl stearate (mono-, di- and/or tristearate), for example PEG-20 glyceryl triisostearate; esters of sugar and of a C8-C24 fatty acid and their oxyalkylenated derivatives, such as polyethoxylated sorbitol esters of C8-C24 fatty acids, in particular Polysorbate 80, such as the product marketed under the name “TWEEN 80” by Croda; ethers of a sugar and of C8-C24 fatty alcohols, such as caprylyl/capryl glucoside; polyoxyethylene alkyl ethers; polyoxyethylene oxypropylene alkyl ethers; fatty acid alkanol amides; alkyl amine oxides; alkyl polyglycosides and silicone surfactants, such as polydimethylsiloxane containing oxyethylene groups and/or oxypropylene groups, for example, PEG-10 dimethicone, bis-PEG/PPG-14/14 dimethicone, bis- PEG/PPG-20/20 dimethicone, and PEG/PPG-20/6 dimethicone, and alkyl dimethicone copolyols, notably those having an alkyl radical with 10 to 22 carbon atoms and having 2 to 50 oxyethylene groups and 2 to 50 oxypropylene groups, such as cetyl dimethicone copolyol (INCI name: Cetyl PEG/PPG-10/1 Dimethicone), and lauryl dimethicone copolyol (INCI name: Lauryl PEG/PPG- 18/18 Methicone); and polyglyceryl fatty acid ester such as polyglyceryl-4 caprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dioleate, polyglyceryl-6 caprylate, polyglyceryl- 2 oleate, and polyglyceryl-6 polyricinoleate; and mixtures thereof.
In addition, mention can be made of alkylpolyglycosides as nonionic surfactants, represented by the following general formula (1): R-0-(G)x(l) in which R represents a branched and/or unsaturated alkyl radical comprising from 14 to 24 carbon atoms, G represents a reduced sugar comprising 5 or 6 carbon atoms and x denotes a value ranging from 1 to 10 and preferably from 1 to 4, and G in particular denotes glucose, fructose or galactose. Mention may be made, as alkyl polyglycosides of this type, of alkyl polyglucosides (G = glucose in the formula (I)) and in particular the compounds of formula (I) in which R more particularly represents an oleyl radical (unsaturated C18 radical) or isostearyl (saturated C18 radical), G denotes glucose and x is a value ranging from 1 to 2, in particular isostearyl glucoside, oleyl glucoside and their mixtures. This alkyl polyglucoside can be used as a mixture with a coemulsifier, more especially with a fatty alcohol and in particular a fatty alcohol having the same fatty chain as that of the alkyl polyglucoside, that is to say comprising from 14 to 24 carbon atoms and having a branched and/or unsaturated chain, for example isostearyl alcohol when the alkyl polyglucoside is isostearyl glucoside and oleyl alcohol when the alkyl polyglucoside is oleyl glucoside. Use may be made, for example, of the mixture of isostearyl glucoside and isostearyl alcohol, sold under the name Montanov WO 18 by Seppic, and also the mixture of octyldodecanol and octyldodecyl xyloside sold under the name Fludanov 20X by Seppic.
The amount of the surfactant(s) in the composition may be from 0.1 to 15% by weight, preferably from 0.5 to 10% by weight, and more preferably from 1 to 5% by weight, relative to the total weight of the composition.
• Thickener
The composition according to the present invention may comprise at least one thickener. Two or more thickeners can be combined. The thickener may be hydrophilic or lipophilic, and preferably lipophilic.
The lipophilic thickener may be in the form of polymer or particles.
The lipophilic polymer thickener may be chosen from carboxyvinyl polymers such as the Carbopol products (carbomers) and the Pemulen products (acrylate/C 10-C30-alkyl acrylate copolymer) or polymers having the INCI name "Poly CIO-30 Alkyl Acrylate", such as the Intelimer® products from Air Products, such as the product Intelimer® IPA 13-1, which is a polystearyl acrylate, or the product 30 Intelimer® IPA 13-6 which is a behenyl polymer.
The lipophilic thickener according to the present invention may be chosen from:
- organomodified clays, which are clays treated with compounds chosen especially from quaternary amines and tertiary amines. Organomodified clays that may be mentioned include organomodified bentonites, such as the product sold under the name Bentone 34 by the company Rheox, and organomodified hectorites such as the products sold under the names Bentone 27 and Bentone 38 by the company Rheox. Mention may be made especially of modified clays such as modified magnesium silicate (Bentone gel® VS38 from Rheox), modified hectorites such as hectorite modified with a C 10 to C22 fatty acid ammonium chloride, for instance hectorite modified with distearyldimethylammonium chloride (disteardimonium hectorite) such as the product sold under the name Bentone 38VCG by the company Elementis or the product sold under the name Bentone 38 CE by the company Rheox, or the product sold under the name Bentone Gel® V5 5V by the company Elementis, or the product sold under the name Bentone gel® ISD V by the company Elementis;
- and mixtures thereof. The amount of the thickener(s) in the composition may be from 0.1 to 10% by weight, preferably from 0.2 to 5% by weight, and more preferably from 0.3 to 3% by weight, relative to the total weight of the composition.
• Inorganic UV filter
The composition according to the present invention may comprise at least one inorganic UV filter. Two or more inorganic UV filters can be combined.
The inorganic UV filter used for the present invention may be active in the UV-A and/or UV-B region. The inorganic UV filter may be hydrophilic and/or lipophilic. The inorganic UV filter is preferably insoluble in solvents such as water and ethanol, commonly used in cosmetics.
The inorganic UV filter used for the present invention is different from the (b) powder of the present invention.
It is preferable that the inorganic UV filter be in the form of a fine particle such that the mean (primary) particle diameter thereof ranges from 1 nm to 150 nm, preferably 5 nm to 100 nm, and more preferably 10 nm to 50 nm. The mean (primary) particle size or mean (primary) particle diameter here is an arithmetic mean diameter.
The inorganic UV filter can be selected from the group consisting of metal oxides which may or may not be coated, and mixtures thereof.
Preferably, the inorganic UV filters may be selected from pigments (mean size of the primary particles: generally from 5 nm to 50 nm, preferably from 10 nm to 50 nm) formed of metal oxides, such as, for example, pigments formed of titanium oxide (amorphous or crystalline in the rutile and/or anatase form), iron oxide, zinc oxide, zirconium oxide or cerium oxide, which are all UV photoprotective agents that are well known per se. Preferably, the inorganic UV filters may be selected from titanium oxide, zinc oxide, and more preferably titanium oxide.
The inorganic UV filter may or may not be coated. The inorganic UV filter may have at least one coating. The coating may comprise at least one compound selected from the group consisting of alumina, silica, aluminum hydroxide, silicones, silanes, fatty acids or salts thereof (such as sodium, potassium, zinc, iron, or aluminum salts), fatty alcohols, lecithin, amino acids, polysaccharides, proteins, alkanolamines, waxes such as beeswax, (meth)acrylic polymers, organic UV filters, and (per)fluoro compounds.
In a known manner, the silicones in the coating(s) may be organosilicon polymers or oligomers comprising a linear or cyclic and branched or cross-linked structure, of variable molecular weight, obtained by polymerization and/or polycondensation of suitable functional silanes and essentially composed of repeated main units in which the silicon atoms are connected to one another via oxygen atoms (siloxane bond), optionally substituted hydrocarbon radicals being connected directly to said silicon atoms via a carbon atom.
The silicones used for the coating(s) can preferably be selected from the group consisting of alkylsilanes, polydialkylsiloxanes, and polyalkylhydrosiloxanes. More preferably still, the silicones are selected from the group consisting of octyltrimethylsilanes, polydimethylsiloxanes, and polymethylhydrosiloxanes. Of course, the inorganic UV filters made of metal oxides may, before their treatment with silicones, have been treated with other surfacing agents, in particular, with cerium oxide, alumina, silica, aluminum compounds, silicon compounds, or their mixtures.
The amount of the inorganic UV filter(s) in the composition may be from 0.5% by weight or more, preferably 1 % by weight or more, and more preferably 1.5% by weight or more, and 15% by weight or less, preferably 10% by weight or less, more preferably 7% by weight or less, and even more preferably 5% weight or less, relative to the total weight of the composition.
• Water
The composition according to the present invention can comprise water.
The amount of water in the composition may be from 2% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, and 60% by weight or less, preferably 50% by weight or less, more preferably 40% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
• Adjuvants
The compositions according to the present invention may also contain various adjuvants conventionally used in compositions for sun care products, which may be selected from a physiologically acceptable medium, anionic, non-ionic, amphoteric or zwitterionic polymers or mixtures thereof, antioxidants, neutralizing agents, alkaline agents, such as sodium hydroxide, sequestering agents, such as trisodium ethylenediamine disuccinate, disodium EDTA, and phytin acid, buffers, such as tromethamine, fragrances, emollients, dispersing agents, dyes and/or pigments, film-forming agents and/or thickeners, ceramides, preservatives, such as phenoxy ethanol and caprylyl glycol, co-preservatives and opacifying agents.
The adjuvants may be present in the composition of the present invention in an amount preferably ranging from 0.01% to 30% by weight, more preferably from 0.1% to 20% by weight, and even more preferably from 0.5% to 10% by weight, relative to the total weight of the composition.
The composition according to the present invention comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, more preferably 1% by weight or less, even more preferably 0.05% by weight or less, and in particular 0.01% by weight, relative to the total weight of the composition.
Most preferably, the composition according to the present invention is free of microplastic filler.
The composition according to the present invention may be intended for use as a cosmetic topical composition. Thus, the composition according to the present invention may be intended for application onto a keratinous substance. Keratinous substance here means a material containing keratin as a main constituent element, and examples thereof include the skin, scalp, nails, lips, hair, and the like. In particular, the composition according to the present invention may be a skin sun care cosmetic composition for protecting skin from UV rays.
The viscosity of the composition according to the present invention is not particularly limited. Preferably, the viscosity of the composition according to the present invention ranges from 1 to 1,000,000 mm2/s, more preferably from 2 mm2/s to 500,000 mm2/s, and even more preferably from 5 mm2/s to 100,000 mm2/s at 25°C. The viscosity of the composition according to the present invention can be measured using a Poiseuille rheometer, at a temperature of 25 °C, according to standard ASTM-D445-97.
The composition according to the present invention can be prepared by mixing ingredients (a) to (d), as essential ingredients, as well as optional ingredient(s), as explained above.
[Cosmetic Process]
The present invention also relates to: a cosmetic process for a keratin substrate, such as skin, comprising applying to the keratin substrate the composition according to the present invention.
The composition according to the present invention may preferably be used as a cosmetic composition. The cosmetic composition may be a sun care composition for protecting keratinous substances, such as skin, from UV rays.
The cosmetic process here means a non-therapeutic cosmetic method for caring for and/or making up the surface of a keratin substrate such as skin.
Therefore, the present invention relates to a cosmetic process for protecting keratinous substances from UV radiation, comprising, at least one step of applying the composition according to the present invention to the keratinous substance, such as skin.
EXAMPLES
The present invention will be described in more detail by way of examples which however should not be construed as limiting the scope of the present invention.
[Compositions]
Each of the W/O emulsion compositions according to Examples 1 and 2 (Ex. 1 and Ex. 2) and Comparative Examples 1 to 8 (Comp. Ex. 1 to Comp. Ex. 8) was prepared by mixing the ingredients listed in the following Tables 1 and 2. Specifically, the W/O emulsion compositions were prepared by first mixing the ingredients of the “oil phase” and the ingredients of the “water phase”, then adding “powder” ingredients and ethanol to the mixture, and then mixing it until it became homogenous. The numerical values in parentheses in the powder ingredients indicate average particle size of the powder ingredients. Titanium dioxide and zinc oxide in the oil phase were used as inorganic UV filters. The numerical values for the amounts of the ingredients are all based on “% by weight” as active raw materials.
[Evaluation]
(Water Resistance)
The following evaluations were conducted in order to determine the water resistant property of each of the compositions.
- Change in Skin Color After applying lg of each of the compositions on the back side of the hand, the composition was dried for 1 to 2 minutes. Subsequently, after putting the hand into a beaker containing 2L of tap water for 1 minute, a change in skin color was observed with the naked eye. The change in skin color was evaluated for each composition under the following criteria.
1 : No skin color change was observed.
2: Slight skin color change was observed.
3: Moderate skin color change was observed.
4: Skin color change was clearly observed.
- Water Clearness
After applying 1 g of each of the compositions on the back side of the hand, the composition was dried for 1 to 2 minutes. Subsequently, after putting the hand into a beaker containing 2L of tap water for 1 minute, a change in the surface of the water was observed with the naked eye. The change in skin color was evaluated for each composition under the following criteria.
1 : No change in the water surface was observed.
2: Slight change in the water surface was observed.
3: Moderate change in the water surface was observed.
4: Change in the water surface was clearly observed.
(Fresh Sensation)
30 mg of each of the compositions was applied on and around a 30 mm x 30 mm area of a panel member’s forearm (n=5) with the fingers. The fresh sensation was evaluated for each composition under the following criteria.
1 : Watery fresh 4: Greasy
(Stability)
The obtained emulsion compositions in a 100 mL were kept at 25°C for 24 hours after they were manufactured. The appearance of each sample was then observed with the naked eye. The stability property was evaluated for each composition under the following criteria.
1 : No phase separation was observed 3: Slight phase separation was observed 4: Phase separation was clearly observed.
The results are shown in Table 3 below. Table 1
Figure imgf000029_0001
Table 2
Figure imgf000030_0001
Table 3
Figure imgf000031_0001
As can be seen from the evaluation results in Table 3, the W/O emulsion composition according to Examples 1 and 2, which include a combination of at least one lipophilic organic UV filter, at least one powder other than microplastic filler, and at least one cationic polymer exerted an improved water resistance property, fresh sensation on application, and a good stability.
On the other hand, the composition according to Comparative Example 1 , which does not include any powder other than microplastic filler but includes microplastic fillers, did not show a good water resistance property because of the inferior water clearness result. The composition according to Comparative Examples 2 and 3, which do not include any cationic polymer, did not show a good water resistance property and showed an inferior stability of W/O emulsion. The composition according to Comparative Examples 4 to 6, which include microplastic fillers in a large amount, showed a poor water resistant property because of the inferior water clearness result.
Therefore, it can be concluded that the W/O emulsion composition according to the present invention is very preferable as a sun care cosmetic composition.

Claims

1. A W/O emulsion composition comprising:
(a) at least one lipophilic organic UV filter,
(b) at least one powder other than microplastic filler,
(c) at least one cationic polymer, and
(d) at least one oil, wherein the composition comprises microplastic filler in an amount of 5% by weight or less, preferably 3% by weight or less, and more preferably 1% by weight or less, or the composition is free of microplastic filler.
2. The composition according to Claim 1 wherein the (b) powder is selected from talc, mica, silica, magnesium aluminum silicate, silica silicate, kaolin, bentone, calcium carbonate, magnesium hydrogen carbonate, hydroxyapatite, boron nitride, fluorphlogopite, sericite, calcinated talc, calcinated mica, calcinated sericite, synthetic mica, perlite, lauroyl lysine, metal soap, bismuth oxychloride, barium sulfate, magnesium carbonate, and natural polymer powders, such as polysaccharide powders, for example, starch, cellulose powder, and mixtures thereof.
3. The composition according to Claim 1 or 2, wherein the average particle size of the (b) powder is 50 pm or less, preferably 20 pm or less, and more preferably 15 pm or less, and is 0.2 pm or more, preferably 0.5 pm or more, and more preferably 1 pm or more.
4. The composition according to any one of Claims 1 to 3, wherein the (c) cationic polymer is selected from quatemized hydroxyethyl celluloses modified with at least one quaternary ammonium group comprising at least one fatty chain.
5. The composition according to any one of Claims 1 to 4, wherein the (c) cationic polymer is selected from quatemized alkylhydroxyethylcelluloses containing C8-C30 fatty chains.
6. The composition according to any one of Claims 1 to 5, which is free of microplastic filler.
7. The composition according to any one of Claims 1 to 6, wherein the (a) lipophilic organic UV filter comprises a combination of at least one lipophilic organic UV-A filter and at least one lipophilic organic UV-B filter.
8. The composition according to any one of Claims 1 to 7, wherein the amount of the (a) lipophilic organic UV filter(s) is 1% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, and even more preferably 15% by weight or more, and is 50% by weight or less, preferably 40% by weight or less, more preferably 30% by weight or less, and even more preferably 25% by weight or less, relative to the total weight of the composition.
9. The composition according to any one of Claims 1 to 8, wherein the amount of the (b) powder(s) is 1% by weight or more, preferably 3% by weight or more, more preferably 5% by weight or more, even more preferably 8% by weight or more, and in particular 10% by weight or more, and is 30% by weight or less, preferably 25% by weight or less, more preferably 20% by weight or less, even more preferably 18% by weight or less, and in particular 15% by weight or less, relative to the total weight of the composition.
10. The composition according to any one of Claims 1 to 9, wherein the amount of the (c) cationic polymer(s) is 0.001% by weight or more, preferably 0.01% by weight or more, and more preferably 0.05% by weight or more, and is 5% by weight or less, preferably 3% by weight or less, more preferably 1% by weight or less, and even more preferably 0.5% by weight or less, relative to the total weight of the composition.
11. The composition according to any one of Claims 1 to 10, wherein the amount of the (d) oil(s) is 3% by weight or more, preferably 5% by weight or more, more preferably 10% by weight or more, even more preferably 15% by weight or more, and in particular 20% by weight or more, and is 50% by weight or less, preferably 40% by weight or less, more preferably 35% by weight or less, and even more preferably 30% by weight or less, relative to the total weight of the composition.
12. The composition according to any one of Claims 1 to 11 , further comprising at least one inorganic UV filter.
13. The composition according to Claim 12, wherein the inorganic UV filter has an average particle size of less than 200 nm.
14. The composition according to Claim 12 or 13, wherein the amount of the inorganic UV filter is 0.5% by weight or more, preferably 1% by weight or more, and more preferably
1.5% by weight or more, and is 15% by weight or less, preferably 10% by weight or less, more preferably 7% by weight or less, and even more preferably 5% weight or less, relative to the total weight of the composition.
15. A cosmetic process for a keratin substrate, such as skin, comprising applying to the keratin substrate the composition according to any one of Claims 1 to 14.
PCT/JP2022/026534 2021-06-30 2022-06-21 Sunscreen w/o emulsion WO2023277194A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020237045187A KR20240013245A (en) 2021-06-30 2022-06-21 Sunscreen W/O Emulsion
CN202280047046.1A CN117597102A (en) 2021-06-30 2022-06-21 Sun protection W/O emulsion

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021-108691 2021-06-30
JP2021108691A JP2023006211A (en) 2021-06-30 2021-06-30 W/O emulsion composition
FR2108145 2021-07-27
FR2108145A FR3125707A1 (en) 2021-07-27 2021-07-27 W/O EMULSION COMPOSITION

Publications (1)

Publication Number Publication Date
WO2023277194A1 true WO2023277194A1 (en) 2023-01-05

Family

ID=82492459

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/026534 WO2023277194A1 (en) 2021-06-30 2022-06-21 Sunscreen w/o emulsion

Country Status (2)

Country Link
KR (1) KR20240013245A (en)
WO (1) WO2023277194A1 (en)

Citations (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2261002A (en) 1941-06-17 1941-10-28 Du Pont Organic nitrogen compounds
US2271378A (en) 1939-08-30 1942-01-27 Du Pont Pest control
US2273780A (en) 1939-12-30 1942-02-17 Du Pont Wax acryalte ester blends
US2375853A (en) 1942-10-07 1945-05-15 Du Pont Diamine derivatives
US2388614A (en) 1942-05-05 1945-11-06 Du Pont Disinfectant compositions
US2454547A (en) 1946-10-15 1948-11-23 Rohm & Haas Polymeric quaternary ammonium salts
US2961347A (en) 1957-11-13 1960-11-22 Hercules Powder Co Ltd Process for preventing shrinkage and felting of wool
US3206462A (en) 1962-10-31 1965-09-14 Dow Chemical Co Quaternary poly(oxyalkylene)alkylbis(diethylenetriamine) compounds
US3227615A (en) 1962-05-29 1966-01-04 Hercules Powder Co Ltd Process and composition for the permanent waving of hair
FR1492597A (en) 1965-09-14 1967-08-18 Union Carbide Corp New cellulose ethers containing quaternary nitrogen
FR1583363A (en) 1967-09-28 1969-10-24
US3589578A (en) 1968-01-20 1971-06-29 Monforts Fa A Tension-relieving device for stretchable sheet material
FR2077143A5 (en) 1970-01-30 1971-10-15 Gaf Corp
FR2080759A1 (en) 1970-02-25 1971-11-19 Gillette Co
US3874870A (en) 1973-12-18 1975-04-01 Mill Master Onyx Corp Microbiocidal polymeric quarternary ammonium compounds
FR2252840A1 (en) 1973-11-30 1975-06-27 Oreal
FR2270846A1 (en) 1974-05-16 1975-12-12 Oreal
US3929990A (en) 1973-12-18 1975-12-30 Millmaster Onyx Corp Microbiocidal polymeric quaternary ammonium compounds
US3966904A (en) 1974-10-03 1976-06-29 Millmaster Onyx Corporation Quaternary ammonium co-polymers for controlling the proliferation of bacteria
US4001432A (en) 1974-10-29 1977-01-04 Millmaster Onyx Corporation Method of inhibiting the growth of bacteria by the application thereto of capped polymers
US4005193A (en) 1974-08-07 1977-01-25 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
FR2316271A1 (en) 1975-07-04 1977-01-28 Oreal NEW QUATERNIZED POLYMERS, THEIR PREPARATION PROCESS, AND THEIR APPLICATION
FR2320330A1 (en) 1974-01-25 1977-03-04 Calgon Corp COMPOSITION OF FUNCTIONAL IONEN POLYMERS AND THEIR USE
US4025653A (en) 1975-04-07 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
US4025627A (en) 1973-12-18 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
US4025617A (en) 1974-10-03 1977-05-24 Millmaster Onyx Corporation Anti-microbial quaternary ammonium co-polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4026945A (en) 1974-10-03 1977-05-31 Millmaster Onyx Corporation Anti-microbial quaternary ammonium co-polymers
US4031307A (en) 1976-05-03 1977-06-21 Celanese Corporation Cationic polygalactomannan compositions
FR2336434A1 (en) 1975-12-23 1977-07-22 Ciba Geigy Ag QUATERNARY POLYMERIC AMMONIUM SALTS, THEIR PREPARATION PROCESS AND THEIR USE
FR2368508A2 (en) 1977-03-02 1978-05-19 Oreal HAIR CONDITIONING COMPOSITION
US4131576A (en) 1977-12-15 1978-12-26 National Starch And Chemical Corporation Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system
FR2393573A1 (en) 1977-06-10 1979-01-05 Gaf Corp HAIR PREPARATIONS CONTAINING A VINYLPYRROLIDONE COPOLYMER
FR2413907A1 (en) 1977-09-20 1979-08-03 Oreal COSMETIC COMPOSITIONS BASED ON QUATERNARY POLYAMMONIUM POLYMERS
EP0080976A1 (en) 1981-11-30 1983-06-08 Ciba-Geigy Ag Mixtures of quaternary polymeric acrylic ammonium salts, quaternary mono- or oligomeric ammonium salts and surfactants, their preparation and their use in cosmetic compositions
EP0122324A1 (en) 1983-04-15 1984-10-24 Miranol Inc. Polyquaternary ammonium compounds and cosmetic compositions containing them
WO2005000903A1 (en) 2003-06-17 2005-01-06 Union Carbide Chemicals & Plastics Technology Corporation Cellulose ethers
JP2009191033A (en) 2008-02-15 2009-08-27 Kose Corp Water-in-oil type sunblock cosmetic
JP2020097552A (en) 2018-12-19 2020-06-25 日本メナード化粧品株式会社 Cosmetic preparations for concavo-convex compensation

Patent Citations (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2271378A (en) 1939-08-30 1942-01-27 Du Pont Pest control
US2273780A (en) 1939-12-30 1942-02-17 Du Pont Wax acryalte ester blends
US2261002A (en) 1941-06-17 1941-10-28 Du Pont Organic nitrogen compounds
US2388614A (en) 1942-05-05 1945-11-06 Du Pont Disinfectant compositions
US2375853A (en) 1942-10-07 1945-05-15 Du Pont Diamine derivatives
US2454547A (en) 1946-10-15 1948-11-23 Rohm & Haas Polymeric quaternary ammonium salts
US2961347A (en) 1957-11-13 1960-11-22 Hercules Powder Co Ltd Process for preventing shrinkage and felting of wool
US3227615A (en) 1962-05-29 1966-01-04 Hercules Powder Co Ltd Process and composition for the permanent waving of hair
US3206462A (en) 1962-10-31 1965-09-14 Dow Chemical Co Quaternary poly(oxyalkylene)alkylbis(diethylenetriamine) compounds
FR1492597A (en) 1965-09-14 1967-08-18 Union Carbide Corp New cellulose ethers containing quaternary nitrogen
FR1583363A (en) 1967-09-28 1969-10-24
US3589578A (en) 1968-01-20 1971-06-29 Monforts Fa A Tension-relieving device for stretchable sheet material
FR2077143A5 (en) 1970-01-30 1971-10-15 Gaf Corp
FR2080759A1 (en) 1970-02-25 1971-11-19 Gillette Co
FR2252840A1 (en) 1973-11-30 1975-06-27 Oreal
US3874870A (en) 1973-12-18 1975-04-01 Mill Master Onyx Corp Microbiocidal polymeric quarternary ammonium compounds
US3929990A (en) 1973-12-18 1975-12-30 Millmaster Onyx Corp Microbiocidal polymeric quaternary ammonium compounds
US4025627A (en) 1973-12-18 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
FR2320330A1 (en) 1974-01-25 1977-03-04 Calgon Corp COMPOSITION OF FUNCTIONAL IONEN POLYMERS AND THEIR USE
FR2270846A1 (en) 1974-05-16 1975-12-12 Oreal
US4005193A (en) 1974-08-07 1977-01-25 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
US3966904A (en) 1974-10-03 1976-06-29 Millmaster Onyx Corporation Quaternary ammonium co-polymers for controlling the proliferation of bacteria
US4025617A (en) 1974-10-03 1977-05-24 Millmaster Onyx Corporation Anti-microbial quaternary ammonium co-polymers
US4026945A (en) 1974-10-03 1977-05-31 Millmaster Onyx Corporation Anti-microbial quaternary ammonium co-polymers
US4001432A (en) 1974-10-29 1977-01-04 Millmaster Onyx Corporation Method of inhibiting the growth of bacteria by the application thereto of capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4025653A (en) 1975-04-07 1977-05-24 Millmaster Onyx Corporation Microbiocidal polymeric quaternary ammonium compounds
FR2316271A1 (en) 1975-07-04 1977-01-28 Oreal NEW QUATERNIZED POLYMERS, THEIR PREPARATION PROCESS, AND THEIR APPLICATION
FR2336434A1 (en) 1975-12-23 1977-07-22 Ciba Geigy Ag QUATERNARY POLYMERIC AMMONIUM SALTS, THEIR PREPARATION PROCESS AND THEIR USE
US4031307A (en) 1976-05-03 1977-06-21 Celanese Corporation Cationic polygalactomannan compositions
FR2368508A2 (en) 1977-03-02 1978-05-19 Oreal HAIR CONDITIONING COMPOSITION
FR2393573A1 (en) 1977-06-10 1979-01-05 Gaf Corp HAIR PREPARATIONS CONTAINING A VINYLPYRROLIDONE COPOLYMER
FR2413907A1 (en) 1977-09-20 1979-08-03 Oreal COSMETIC COMPOSITIONS BASED ON QUATERNARY POLYAMMONIUM POLYMERS
US4131576A (en) 1977-12-15 1978-12-26 National Starch And Chemical Corporation Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system
EP0080976A1 (en) 1981-11-30 1983-06-08 Ciba-Geigy Ag Mixtures of quaternary polymeric acrylic ammonium salts, quaternary mono- or oligomeric ammonium salts and surfactants, their preparation and their use in cosmetic compositions
EP0122324A1 (en) 1983-04-15 1984-10-24 Miranol Inc. Polyquaternary ammonium compounds and cosmetic compositions containing them
WO2005000903A1 (en) 2003-06-17 2005-01-06 Union Carbide Chemicals & Plastics Technology Corporation Cellulose ethers
JP2009191033A (en) 2008-02-15 2009-08-27 Kose Corp Water-in-oil type sunblock cosmetic
JP2020097552A (en) 2018-12-19 2020-06-25 日本メナード化粧品株式会社 Cosmetic preparations for concavo-convex compensation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 11 October 2011 (2011-10-11), ANONYMOUS: "Sun Block Lotion SPF 40", XP055908737, retrieved from https://www.gnpd.com/sinatra/recordpage/1647711/ Database accession no. 1647711 *
DATABASE GNPD [online] MINTEL; 16 April 2018 (2018-04-16), ANONYMOUS: "Perfect UV Protector SPF 50+/PA++++", XP055908480, retrieved from https://www.gnpd.com/sinatra/recordpage/5591817/ Database accession no. 5591817 *
DATABASE GNPD [online] MINTEL; 17 October 2019 (2019-10-17), ANONYMOUS: "Advanced Anti-Aging Sunscreen SPF 50+ PA+++", XP055908722, retrieved from https://www.gnpd.com/sinatra/recordpage/6956183/ Database accession no. 6956183 *
DATABASE WPI Week 202005, Derwent World Patents Index; AN 2020-56559R, XP002806132 *

Also Published As

Publication number Publication date
KR20240013245A (en) 2024-01-30

Similar Documents

Publication Publication Date Title
JP7346660B2 (en) Composition containing polyion complex particles and oil
KR102456244B1 (en) Composition containing polyion complex comprising a cellulosic cationic polymer having one or more fatty chains and an oil
JP7063549B2 (en) Combination of polyion complex particles with a non-polymeric acid or base having two or more dissociation constants
US11452676B2 (en) Combination of polyion complex particle and non-polymeric base having two or more dissociation constants
WO2023277194A1 (en) Sunscreen w/o emulsion
US20230025603A1 (en) Sun care composition
US20230225958A1 (en) Composition comprising pigment coated with isopropyl titanium triisostearate
JP2023006211A (en) W/O emulsion composition
EP3393600B1 (en) Sun care composition based on small particle o/w emulsion
JP7403978B2 (en) W/O composition containing polyion complex and organic UV filter
FR3125707A1 (en) W/O EMULSION COMPOSITION
KR102591788B1 (en) Emulsion with high oil content
BR112019025398B1 (en) COMPOSITION, PROCESS FOR PREPARING A FILM, COSMETIC PROCESS FOR A KERATIN SUBSTRATE AND USE OF THE COMPOSITION
US20210154106A1 (en) Tinted mineral sunscreen compositions
JP2020033299A (en) Foamable composition containing oil

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22741012

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20237045187

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020237045187

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE